合併財務報表 |
105 |
||||
106 |
||||
109 |
||||
111 |
||||
112 |
||||
113 |
||||
114 |
||||
115 |
||||
116 |
||||
117 |
117 | 注1 | – | 重大會計政策的編制基礎和摘要 | |||
129 | 注2 | – | 公允價值計量 | |||
136 | 注3 | – | 重大交易 | |||
137 | 注4 | – | 證券 | |||
138 | 注5 | – | 貸款 | |||
144 | 注6 | – | 結構化實體和金融資產的終止確認 | |||
148 | 注7 | – | 財產和設備 | |||
148 | 附註8 | – | 善意、軟件和其他無形資產 | |||
150 | 注9 | – | 其他資產 | |||
151 | 附註10 | – | 存款 | |||
151 | 注11 | – | 其他負債 | |||
151 | 注12 | – | 衍生工具 | |||
155 | 注13 | – | 指定會計對沖 | |||
159 | 附註14 | – | 次級債務 | |||
160 | 注15 | – | 普通股和優先股以及其他股權工具 |
165 | 附註16 | – | 基於股份的支付 | |||
167 | 附註17 | – | 離職後福利 | |||
171 | 注18 | – | 所得稅 | |||
174 | 附註19 | – | ||||
174 | 注20 | – | 承諾、擔保和質押資產 | |||
176 | 注21 | – | 或有負債和撥備 | |||
179 | 注22 | – | 信用風險集中 | |||
180 | 附註23 | – | 關聯方交易 | |||
181 | 附註24 | – | 對股權覈算的聯營公司和合資企業的投資 | |||
182 | 附註25 | – | 重要子公司 | |||
183 | 附註26 | – | 金融工具-披露 | |||
184 | 附註27 | – | 抵銷金融資產和負債 | |||
184 | 附註28 | – | 利息收支 | |||
185 | 注29 | – | 分段和地理信息 | |||
187 | 附註30 | – | 未來會計政策變化 |
104 |
CIBC 2024 |
合併財務報表 |
維克多·G·多迪格 |
羅伯特·塞德蘭 |
|||
總裁與首席執行官 | 首席財務官 | 2024年12月4日 |
CIBC 2024 |
|
105 |
|
106 |
CIBC 2024 |
CIBC 2024 |
|
107 |
|
108 |
CIBC 2024 |
Consolidated financial statements |
Allowance for credit losses | ||
Description of the matter |
As described in Note 1 and Note 5 of the consolidated financial statements, CIBC has recognized $4.1 billion in expected credit loss (ECL) allowances on its consolidated balance sheet. ECL allowances represent credit losses that reflect an unbiased and probability-weighted amount that is determined by evaluating a range of possible outcomes and reasonable and supportable information about past events, current conditions, and forecasts of future economic conditions. ECL allowances are measured at amounts equal to either (i) 12-month ECL; or (ii) lifetime ECL for those financial instruments that have experienced a significant increase in credit risk (SICR) since initial recognition or when there is objective evidence of impairment.Auditing the allowance for credit losses was complex, involved significant auditor judgment, and required the involvement of specialists due to the inherent complexity of the models, the large volume of data used, assumptions, judgments, and the interrelationship of these variables in measuring the ECL. Significant assumptions and judgments with respect to the estimation of the allowance for credit losses include (i) the determination of when a loan has experienced a SICR; (ii) the forecast of forward-looking information (FLI) for multiple economic scenarios and the probability weighting of those scenarios; (iii) the models and methodologies used for the calculation of both 12-month and lifetime credit losses; and (iv) the application of expert credit judgment. Management has applied a heightened use of judgment in the areas noted above, when assessing the impact of the uncertain macroeconomic environment on the allowance for credit losses. | |
How we addressed the matter in our audit |
We obtained an understanding, evaluated the design and tested the operating effectiveness of management’s controls over the allowance for credit losses, with the assistance of our internal specialists. The controls we tested included, amongst others, controls over technology, model validation and monitoring, economic forecasting, data completeness and accuracy, the determination of internal risk ratings for non-retail loans, and the governance and oversight controls over the review of the overall ECL, including the application of expert credit judgment.To test the allowance for credit losses, amongst other procedures, we assessed, with the assistance of our credit risk specialists, whether the methodology and assumptions used in significant models that estimate ECL are consistent with the requirements of IFRS 9. For a sample of models, our credit risk specialists reperformed the model validation and monitoring tests performed by management. This included an assessment of the thresholds used to determine a SICR. For a sample of FLI variables, with the assistance of our economic specialists, we evaluated management’s forecasting methodology and compared management’s FLI to independently derived forecasts and publicly available information. We also evaluated the scenario probability weights used in the ECL models. With the assistance of our credit risk specialists, we also evaluated management’s methodology and governance |
CIBC 2024 |
|
109 |
|
Consolidated financial statements |
over the application of expert credit judgment by evaluating that the amounts recorded were reflective of underlying credit and/or economic conditions. We tested the completeness and accuracy of data used in the measurement of the ECL by agreeing to source documents and systems and evaluated a sample of non-retail borrower risk ratings against CIBC’s risk rating scale. On a sample basis, we recalculated the ECL to test the mathematical accuracy of management’s models. We also assessed the adequacy of the disclosures related to allowance for credit loss. | ||
Fair value measurement of derivatives | ||
Description of the matter |
As described in Note 2 and Note 12 of the consolidated financial statements, CIBC has recognized $36.4 billion in derivative assets and $40.7 billion in derivative liabilities. The portfolio of derivative instruments is presented by level within the fair value hierarchy, with the majority of the portfolio classified as Level 2. While derivative instruments classified as Level 1 have quoted market prices, those classified as Level 2 and 3 require valuation techniques that use observable and non-observable market inputs and involve the application of management judgment.Auditing the valuation of certain derivatives was complex and required the application of significant auditor judgment and involvement of valuation specialists where the fair value was determined based on complex models and/or significant non-observable market inputs. The inputs and modelling assumptions used to determine fair values that were subject to significant auditor judgment included, amongst others, correlations, volatilities and credit spreads. The valuation of derivatives is sensitive to these inputs as they are forward-looking and could be affected by future economic and market conditions. | |
How we addressed the matter in our audit |
We obtained an understanding, evaluated the design and tested the operating effectiveness of management’s controls over the valuation of CIBC’s derivatives portfolio, with the assistance of our internal specialists. The controls we tested included, amongst others, controls over technology, the development and validation of models used to determine the fair value of derivatives, and controls over the independent price verification process, including the integrity of significant inputs described above. To test the valuation of these derivatives, our audit procedures included, amongst others, an evaluation of the methodologies and significant inputs used by CIBC. With the assistance of our valuation specialists, we performed an independent valuation for a sample of derivatives to assess the modelling assumptions and significant inputs used by CIBC to estimate the fair value. We independently obtained significant inputs and assumptions from external market data, where available, in performing our independent valuation. For a sample of models, and with the assistance of our valuation specialists, we assessed the valuation methodologies used by CIBC to determine fair values. We also assessed the adequacy of the disclosures related to the fair value measurement of derivatives. | |
Measurement of uncertain tax provisions | ||
Description of the matter |
As described in Note 1 and Note 18 of the consolidated financial statements, CIBC has disclosed its significant accounting judgments, estimates and assumptions in relation to accounting for uncertainty in income taxes. CIBC operates in a tax environment with constantly evolving and complex tax legislation for financial institutions. Uncertainty in tax positions may arise as tax legislation is subject to interpretation. Estimating uncertain tax provisions requires management judgment to be applied in the interpretation of tax laws across the various jurisdictions in which CIBC operates. This includes significant judgment in the determination of whether it is probable that CIBC’s tax filing positions will be sustained relating to certain complex tax positions and the measurement of such provisions when recognized. Auditing CIBC’s uncertain tax provisions required the involvement of our tax professionals and the application of judgment, including the interpretation of applicable tax legislation and jurisprudence. | |
How we addressed the matter in our audit |
With the assistance of our tax professionals, we obtained an understanding, evaluated the design and tested the operating effectiveness of management’s controls over CIBC’s uncertain tax provisions. This included, amongst others, controls over management’s assessment of the technical merits of tax positions and the process related to the measurement of any related income tax provisions. With the assistance of our tax professionals, our audit procedures included, amongst others, an assessment of the technical merits of income tax positions taken by CIBC and the measurement of any related uncertain tax provisions recorded. We inspected and evaluated correspondence from the relevant income tax authorities, income tax advice obtained by CIBC from external advisors including income tax opinions, CIBC’s interpretations of tax laws and the assessment thereof with respect to uncertain tax positions. We evaluated the reasonability of CIBC’s treatment of any new information received during the year relating to these uncertain tax positions. We also assessed the adequacy of the disclosures related to uncertain tax positions. |
11 0 |
CIBC 2024 |
Consolidated financial statements |
CIBC 2024 |
|
11 1 |
|
Consolidated financial statements |
Millions of Canadian dollars, as at October 31 |
2024 |
2023 (1) |
||||||
ASSETS |
||||||||
Cash and non-interest-bearing deposits with banks |
$ |
$ | ||||||
Interest-bearing deposits with banks |
||||||||
Securities (Note 4) |
||||||||
Cash collateral on securities borrowed |
||||||||
Securities purchased under resale agreements |
||||||||
Loans (Note 5) |
||||||||
Residential mortgages |
||||||||
Personal |
||||||||
Credit card |
||||||||
Business and government |
||||||||
Allowance for credit losses |
( |
) |
( |
) | ||||
Other |
||||||||
Derivative instruments (Note 12) |
||||||||
Customers’ liability under acceptances |
||||||||
Property and equipment (Note 7) |
||||||||
Goodwill (Note 8) |
||||||||
Software and other intangible assets (Note 8) |
||||||||
Investments in equity-accounted associates and joint ventures (Note 2 4 ) |
||||||||
Deferred tax assets (Note 1 8 ) |
||||||||
Other assets (Note 9) |
||||||||
$ |
$ | |
||||||
LIABILITIES AND EQUITY |
||||||||
Deposits (Note 10) |
||||||||
Personal |
$ |
$ | ||||||
Business and government |
||||||||
Bank |
||||||||
Secured borrowings |
||||||||
Obligations related to securities sold short |
||||||||
Cash collateral on securities lent |
||||||||
Obligations related to securities sold under repurchase agreements |
||||||||
Other |
||||||||
Derivative instruments (Note 12) |
||||||||
Acceptances |
||||||||
Deferred tax liabilities (Note 1 8 ) |
||||||||
Other liabilities (Note 11) |
||||||||
Subordinated indebtedness (Note 14) |
||||||||
Equity |
||||||||
Preferred shares and other equity instruments (Note 15) |
||||||||
Common shares (Note 15) |
||||||||
Contributed surplus |
||||||||
Retained earnings |
||||||||
Accumulated other comprehensive income (AOCI) |
||||||||
Total shareholders’ equity |
||||||||
Non-controlling interests |
||||||||
Total equity |
||||||||
$ |
$ |
(1) | Certain comparative amounts have been restated to reflect the adoption of IFRS 17 “Insurance Contracts” (IFRS 17) in the first quarter of 2024. See Note 1 to the consolidated financial statements for additional details. |
Victor G. Dodig |
Mary Lou Maher | |
President and Chief Executive Officer |
Director |
11 2 |
CIBC 2024 |
Consolidated financial statements |
Millions of Canadian dollars, except as noted, for the year ended October 31 |
2024 |
2023 (1) |
||||||
Interest income (Note 28) (2) |
||||||||
Loans |
$ |
$ | |
|||||
Securities |
||||||||
Securities borrowed or purchased under resale agreements |
||||||||
Deposits with banks and other |
||||||||
Interest expense (Note 2 8 ) |
||||||||
Deposits |
||||||||
Securities sold short |
||||||||
Securities lent or sold under repurchase agreements |
||||||||
Subordinated indebtedness |
||||||||
Other |
||||||||
Net interest income |
||||||||
Non-interest income |
||||||||
Underwriting and advisory fees |
||||||||
Deposit and payment fees |
||||||||
Credit fees |
||||||||
Card fees |
||||||||
Investment management and custodial fees |
||||||||
Mutual fund fees |
||||||||
Income from insurance activities, net (1) |
||||||||
Commissions on securities transactions |
||||||||
Gains (losses) from financial instruments measured/designated at fair value through profit or loss (FVTPL), net |
||||||||
Gains (losses) from debt securities measured at fair value through other comprehensive income (FVOCI) and amortized cost, net |
||||||||
Foreign exchange other than trading (FXOTT) |
||||||||
Income from equity-accounted associates and joint ventures (Note 2 4 ) |
||||||||
Other |
||||||||
Total revenue |
||||||||
Provision for credit losses (Note 5) |
||||||||
Non-interest expenses |
||||||||
Employee compensation and benefits |
||||||||
Occupancy costs |
||||||||
Computer, software and office equipment |
||||||||
Communications |
||||||||
Advertising and business development |
||||||||
Professional fees |
||||||||
Business and capital taxes |
||||||||
Other (Notes 3 and 8) |
||||||||
Income before income taxes |
||||||||
Income taxes (Note 1 8 ) |
||||||||
Net income |
$ |
$ | ||||||
Net income attributable to non-controlling interests |
$ |
$ | ||||||
Preferred shareholders and other equity instrument holders |
$ |
$ | ||||||
Common shareholders |
||||||||
Net income attributable to equity shareholders |
$ |
$ | ||||||
Earnings per share (EPS) (Note 19 ) |
||||||||
Basic |
$ |
$ | ||||||
Diluted |
||||||||
Dividends per common share (Note 15) |
(1) | Certain comparative amounts have been restated to reflect the adoption of IFRS 17 in the first quarter of 2024. See Note 1 to the consolidated financial statements for additional details. |
(2) | Interest income included $ |
CIBC 2024 |
|
11 3 |
Consolidated financial statements |
Millions of Canadian dollars, for the year ended October 31 |
2024 |
2023 (1) |
||||||
Net income |
$ |
$ | ||||||
Other comprehensive income (loss) (OCI), net of income tax, that is subject to subsequent reclassification to net income |
||||||||
Net foreign currency translation adjustments |
||||||||
Net gains (losses) on investments in foreign operations |
||||||||
Net gains (losses) on hedges of investments in foreign operations |
( |
) |
( |
) | ||||
Net change in debt securities measured at FVOCI |
||||||||
Net gains (losses) on debt securities measured at FVOCI |
||||||||
Net (gains) losses reclassified to net income |
( |
) |
( |
) | ||||
Net change in cash flow hedges |
||||||||
Net gains (losses) on derivatives designated as cash flow hedges |
( |
) | ||||||
Net (gains) losses reclassified to net income |
( |
) |
( |
) | ||||
( |
) | |||||||
OCI, net of income tax, that is not subject to subsequent reclassification to net income |
||||||||
Net gains (losses) on post-employment defined benefit plans |
( |
) | ||||||
Net gains (losses) due to fair value change of fair value option (FVO) liabilities attributable to changes in credit risk |
( |
) |
( |
) | ||||
Net gains (losses) on equity securities designated at FVOCI |
( |
) |
||||||
( |
) | |||||||
Total OCI (2) |
( |
) | ||||||
Comprehensive income |
$ |
$ | ||||||
Comprehensive income attributable to non-controlling interests |
$ |
$ | ||||||
Preferred shareholders and other equity instrument holders |
$ |
$ | ||||||
Common shareholders |
||||||||
Comprehensive income attributable to equity shareholders |
$ |
$ | |
(1) | Certain comparative amounts have been restated to reflect the adoption of IFRS 17 in the first quarter of 2024. See Note 1 to the consolidated financial statements for additional details. |
(2) | Includes $ |
Millions of Canadian dollars, for the year ended October 31 |
2024 |
2023 |
||||||
Income tax (expense) benefit allocated to each component of OCI |
||||||||
Subject to subsequent reclassification to net income |
||||||||
Net foreign currency translation adjustments |
||||||||
Net gains (losses) on investments in foreign operations |
$ |
( |
) |
$ | ( |
) | ||
Net gains (losses) on hedges of investments in foreign operations |
– |
|||||||
( |
) |
– | ||||||
Net change in debt securities measured at FVOCI |
||||||||
Net gains (losses) on debt securities measured at FVOCI |
( |
) |
( |
) | ||||
Net (gains) losses reclassified to net income |
||||||||
( |
) |
( |
) | |||||
Net change in cash flow hedges |
||||||||
Net gains (losses) on derivatives designated as cash flow hedges |
( |
) |
||||||
Net (gains) losses reclassified to net income |
||||||||
( |
) |
|||||||
Not subject to subsequent reclassification to net income |
||||||||
Net gains (losses) on post-employment defined benefit plans |
( |
) |
||||||
Net gains (losses) due to fair value change of FVO liabilities attributable to changes in credit risk |
||||||||
Net gains (losses) on equity securities designated at FVOCI |
( |
) | ||||||
$ |
( |
) |
$ | |
11 4 |
CIBC 2024 |
Consolidated financial statements |
Millions of Canadian dollars, for the year ended October 31 |
2024 |
2023 (1) |
||||||
Preferred shares and other equity instruments (Note 15) |
||||||||
Balance at beginning of year |
$ |
$ | ||||||
Issue of preferred shares and limited recourse capital notes (LRCNs) |
– | |||||||
Redemption of preferred shares |
( |
) |
– | |||||
Treasury shares |
( |
) |
||||||
Balance at end of year |
$ |
$ | ||||||
Common shares (Note 15) |
||||||||
Balance at beginning of year |
$ |
$ | ||||||
Issue of common shares |
||||||||
Purchase of common shares for cancellation |
( |
) |
– | |||||
Treasury shares |
– |
( |
) | |||||
Balance at end of year |
$ |
$ | |
|||||
Contributed surplus |
||||||||
Balance at beginning of year |
$ |
$ | ||||||
Compensation expense arising from equity-settled share-based awards |
||||||||
Exercise of stock options and settlement of other equity-settled share-based awards |
( |
) |
( |
) | ||||
Other |
||||||||
Balance at end of year |
$ |
$ | ||||||
Retained earnings |
||||||||
Balance at beginning of year before accounting policy changes |
n/a |
$ | ||||||
Impact of adopting IFRS 17 at November 1, 2022 |
n/a |
( |
) | |||||
Balance at beginning of year |
$ |
|||||||
Net income attributable to equity shareholders |
||||||||
Dividends and distributions (Note 15) |
||||||||
Preferred and other equity instruments |
( |
) |
( |
) | ||||
Common |
( |
) |
( |
) | ||||
Premium on purchase of common shares for cancellation |
( |
) |
– | |||||
Realized gains (losses) on equity securities designated at FVOCI reclassified from AOCI |
( |
) |
– | |||||
Other |
( |
) |
– | |||||
Balance at end of year |
$ |
$ | ||||||
AOCI, net of income tax |
||||||||
AOCI, net of income tax, that is subject to subsequent reclassification to net income |
||||||||
Net foreign currency translation adjustments |
||||||||
Balance at beginning of year |
$ |
$ | ||||||
Net change in foreign currency translation adjustments |
||||||||
Balance at end of year |
$ |
$ | ||||||
Net gains (losses) on debt securities measured at FVOCI |
||||||||
Balance at beginning of year |
$ |
( |
) |
$ | ( |
) | ||
Net change in debt securities measured at FVOCI |
||||||||
Balance at end of year |
$ |
( |
) |
$ | ( |
) | ||
Net gains (losses) on cash flow hedges |
||||||||
Balance at beginning of year |
$ |
( |
) |
$ | ( |
) | ||
Net change in cash flow hedges |
( |
) | ||||||
Balance at end of year |
$ |
$ | ( |
) | ||||
AOCI, net of income tax, that is not subject to subsequent reclassification to net income |
||||||||
Net gains (losses) on post-employment defined benefit plans |
||||||||
Balance at beginning of year |
$ |
$ | ||||||
Net change in post-employment defined benefit plans |
( |
) | ||||||
Balance at end of year |
$ |
$ | ||||||
Net gains (losses) due to fair value change of FVO liabilities attributable to changes in credit risk |
||||||||
Balance at beginning of year |
$ |
$ | ||||||
Net change attributable to changes in credit risk |
( |
) |
( |
) | ||||
Balance at end of year |
$ |
( |
) |
$ | ||||
Net gains (losses) on equity securities designated at FVOCI |
||||||||
Balance at beginning of year |
$ |
$ | ( |
) | ||||
Net gains (losses) on equity securities designated at FVOCI |
( |
) |
||||||
Realized (gains) losses on equity securities designated at FVOCI reclassified to retained earnings |
– | |||||||
Balance at end of year |
$ |
$ | ||||||
Total AOCI, net of income tax |
$ |
$ | ||||||
Non-controlling interests |
||||||||
Balance at beginning of year |
$ |
$ | ||||||
Net income attributable to non-controlling interests |
||||||||
Dividends |
( |
) |
( |
) | ||||
Other |
||||||||
Balance at end of year |
$ |
$ | ||||||
Equity at end of year |
$ |
$ |
(1) | Certain comparative amounts have been restated to reflect the adoption of IFRS 17 in the first quarter of 2024. See Note 1 to the consolidated financial statements for additional details. |
n/a |
Not applicable. |
CIBC 2024 |
|
11 5 |
Consolidated financial statements |
Millions of Canadian dollars, for the year ended October 31 |
2024 |
2023 (1) |
||||||
Cash flows provided by (used in) operating activities |
||||||||
Net income |
$ |
$ | ||||||
Adjustments to reconcile net income to cash flows provided by (used in) operating activities: |
||||||||
Provision for credit losses |
||||||||
Amortization and impairment (2) |
||||||||
Stock options and restricted shares expense |
||||||||
Deferred income taxes |
( |
) |
( |
) | ||||
Losses (gains) from debt securities measured at FVOCI and amortized cost |
( |
) |
( |
) | ||||
Net losses (gains) on disposal of property and equipment |
( |
) |
( |
) | ||||
Other non-cash items, net |
( |
) |
||||||
Net changes in operating assets and liabilities |
||||||||
Interest-bearing deposits with banks |
( |
) |
( |
) | ||||
Loans, net of repayments |
( |
) |
( |
) | ||||
Deposits, net of withdrawals |
||||||||
Obligations related to securities sold short |
||||||||
Accrued interest receivable |
( |
) |
( |
) | ||||
Accrued interest payable |
||||||||
Derivative assets |
( |
) |
||||||
Derivative liabilities |
( |
) |
( |
) | ||||
Securities measured at FVTPL |
( |
) |
( |
) | ||||
Other assets and liabilities measured/designated at FVTPL |
||||||||
Current income taxes |
( |
) |
||||||
Cash collateral on securities lent |
( |
) |
||||||
Obligations related to securities sold under repurchase agreements |
||||||||
Cash collateral on securities borrowed |
( |
) |
||||||
Securities purchased under resale agreements |
( |
) |
( |
) | ||||
Other, net |
||||||||
Cash flows provided by (used in) financing activities |
||||||||
Issue of subordinated indebtedness |
||||||||
Redemption/repurchase/maturity of subordinated indebtedness |
( |
) |
( |
) | ||||
Issue of preferred shares and limited recourse capital notes, net of issuance cost |
– | |||||||
Redemption of preferred shares |
( |
) |
– | |||||
Issue of common shares for cash |
||||||||
Purchase of common shares for cancellation |
( |
) |
– | |||||
Net sale (purchase) of treasury shares |
( |
) |
– | |||||
Dividends and distributions paid |
( |
) |
( |
) | ||||
Repayment of lease liabilities |
( |
) |
( |
) | ||||
( |
) |
( |
) | |||||
Cash flows provided by (used in) investing activities |
||||||||
Purchase of securities measured/designated at FVOCI and amortized cost |
( |
) |
( |
) | ||||
Proceeds from sale of securities measured/designated at FVOCI and amortized cost |
||||||||
Proceeds from maturity of debt securities measured at FVOCI and amortized cost |
||||||||
Net sale (purchase) of property, equipment, software and other intangible assets |
( |
) |
( |
) | ||||
( |
) |
( |
) | |||||
Effect of exchange rate changes on cash and non-interest-bearing deposits with banks |
||||||||
Net increase (decrease) in cash and non-interest-bearing deposits with banks during the year |
( |
) |
( |
) | ||||
Cash and non-interest-bearing deposits with banks at beginning of year |
||||||||
Cash and non-interest-bearing deposits with banks at end of year (3) |
$ |
$ | ||||||
Cash interest paid |
$ |
$ | ||||||
Cash interest received |
||||||||
Cash dividends received |
||||||||
Cash income taxes paid |
(1) | Certain comparative amounts have been restated to reflect the adoption of IFRS 17 in the first quarter of 2024. See Note 1 to the consolidated financial statements for additional details. |
(2) | Comprises amortization and impairment of buildings, right-of-use |
(3) | Includes restricted cash of $ |
11 6 |
CIBC 2024 |
Consolidated financial statements |
Note 1 |
Basis of preparation and summary of material accounting policies |
CIBC 2024 |
|
11 7 |
Consolidated financial statements |
I) | The business purpose of the portfolio; |
II) | The risks that are being managed and the type of business activities that are being carried out on a day-to-day |
III) | The basis on which performance of the portfolio is being evaluated; and |
IV) | The frequency and significance of sales activity. |
1 18 |
CIBC 2024 |
Consolidated financial statements |
• | The probability of default (PD) is an estimate of the likelihood of default over a given time horizon; |
• | The loss given default (LGD) is an estimate of the loss arising in the case where a default occurs at a given time; and |
• | The exposure at default (EAD) is an estimate of the exposure at a future default date. |
CIBC 2024 |
|
1 19 |
Consolidated financial statements |
12 0 |
CIBC 2024 |
Consolidated financial statements |
• | Our contractual right to receive cash flows from the assets has expired; or |
• | We transfer our contractual rights to receive the cash flows of the financial asset or where applicable the transfer also meets the criteria of a qualifying pass-through arrangement, and have: (i) transferred substantially all the risks and rewards of ownership, or (ii) neither retained nor transferred substantially all the risks and rewards, but have not retained control. |
CIBC 2024 |
|
12 1 |
Consolidated financial statements |
12 2 |
CIBC 2024 |
Consolidated financial statements |
CIBC 2024 |
|
12 3 |
Consolidated financial statements |
• | Buildings – |
• | Computer equipment – |
• | Office furniture, equipment and other – |
• | Leasehold improvements – |
• | Software – |
• | Contract-based intangibles – |
• | Core deposit and customer relationship intangibles – |
12 4 |
CIBC 2024 |
Consolidated financial statements |
CIBC 2024 |
|
12 5 |
|
Consolidated financial statements |
12 6 |
CIBC 2024 |
Consolidated financial statements |
CIBC 2024 |
|
12 7 |
Consolidated financial statements |
$ millions |
Reported as at October 31, 2022 |
IFRS 17 transitional adjustments |
Restated as at opening November 1, 2022 |
|||||||||
Assets |
||||||||||||
Deferred tax assets |
$ | $ | $ | |||||||||
Other assets |
( |
) | ||||||||||
Liabilities and equity |
||||||||||||
Other liabilities |
$ | $ | $ | |||||||||
Retained earnings |
|
( |
) | |
1 28 |
CIBC 2024 |
Consolidated financial statements |
Note 2 |
Fair value measurement |
• | Level 1 – Unadjusted quoted market prices in active markets for identical assets or liabilities we can access at the measurement date. Bid prices, ask prices or prices within the bid and ask, which are the most representative of the fair value, are used as appropriate to measure fair value. Fair value is best evidenced by an independent quoted market price for the same instrument in an active market. An active market is one where transactions are occurring with sufficient frequency and volume to provide quoted prices on an ongoing basis. |
• | Level 2 – Quoted prices for identical assets or liabilities in markets that are inactive or observable market quotes for similar instruments, or use of valuation techniques where all significant inputs are observable. Inactive markets may be characterized by a significant decline in the volume and level of observed trading activity or through large or erratic bid/offer spreads. In instances where traded markets do not exist or are not considered sufficiently active, we measure fair value using valuation models. |
• | Level 3 – Non-observable or indicative prices or use of valuation techniques where one or more significant inputs are non-observable. |
CIBC 2024 |
|
1 29 |
Consolidated financial statements |
130 |
CIBC 2024 |
Consolidated financial statements |
Carrying value | ||||||||||||||||||||||||||||||
$ millions, as at October 31 | Amortized cost |
Mandatorily measured at FVTPL |
Designated at FVTPL |
Fair value through OCI |
Total | Fair value |
Fair value over (under) carrying value |
|||||||||||||||||||||||
2024 |
Financial assets |
|||||||||||||||||||||||||||||
Cash and deposits with banks |
$ |
$ |
– |
$ |
– |
$ |
– |
$ |
$ |
$ |
– |
|||||||||||||||||||
Securities |
– |
( |
) | |||||||||||||||||||||||||||
Cash collateral on securities borrowed |
– |
– |
– |
– |
||||||||||||||||||||||||||
Securities purchased under resale agreements |
– |
– |
– |
|||||||||||||||||||||||||||
Loans |
||||||||||||||||||||||||||||||
Residential mortgages |
– |
– |
( |
) | ||||||||||||||||||||||||||
Personal |
– |
– |
– |
|||||||||||||||||||||||||||
Credit card |
– |
– |
– |
|||||||||||||||||||||||||||
Business and government |
– |
|||||||||||||||||||||||||||||
Derivative instruments |
– |
– |
– |
– |
||||||||||||||||||||||||||
Customers’ liability under acceptances |
– |
– |
– |
– |
||||||||||||||||||||||||||
Other assets | – |
– |
– |
|||||||||||||||||||||||||||
Financial liabilities |
||||||||||||||||||||||||||||||
Deposits |
||||||||||||||||||||||||||||||
Personal |
$ |
$ |
– |
$ |
$ |
– |
$ |
$ |
$ |
|||||||||||||||||||||
Business and government |
– |
– |
||||||||||||||||||||||||||||
Bank |
– |
– |
– |
– |
||||||||||||||||||||||||||
Secured borrowings |
– |
– |
||||||||||||||||||||||||||||
Derivative instruments | – |
– |
– |
– |
||||||||||||||||||||||||||
Acceptances | – |
– |
– |
– |
||||||||||||||||||||||||||
Obligations related to securities sold short |
– |
– |
– |
– |
||||||||||||||||||||||||||
Cash collateral on securities lent |
– |
– |
– |
– |
||||||||||||||||||||||||||
Obligations related to securities sold under repurchase agreements |
– |
– |
– |
|||||||||||||||||||||||||||
Other liabilities | – |
– |
||||||||||||||||||||||||||||
Subordinated indebtedness | – |
– |
– |
|||||||||||||||||||||||||||
2023 |
Financial assets |
|||||||||||||||||||||||||||||
Cash and deposits with banks |
$ | $ | – | $ | – | $ | – | $ | $ | $ | – | |||||||||||||||||||
Securities |
– | |
( |
) | ||||||||||||||||||||||||||
Cash collateral on securities borrowed |
– | – | – | – | ||||||||||||||||||||||||||
Securities purchased under resale agreements |
– | – | – | |||||||||||||||||||||||||||
Loans |
||||||||||||||||||||||||||||||
Residential mortgages |
– | – | ( |
) | ||||||||||||||||||||||||||
Personal |
– | – | – | ( |
) | |||||||||||||||||||||||||
Credit card |
– | – | – | |||||||||||||||||||||||||||
Business and government |
– | ( |
) | |||||||||||||||||||||||||||
Derivative instruments |
– | – | – | – | ||||||||||||||||||||||||||
Customers’ liability under acceptances |
– | – | – | – | ||||||||||||||||||||||||||
Other assets | – | – | – | – | ||||||||||||||||||||||||||
Financial liabilities |
||||||||||||||||||||||||||||||
Deposits |
||||||||||||||||||||||||||||||
Personal |
$ | |
$ | – | $ | |
$ | – | $ | |
$ | |
$ | ( |
) | |||||||||||||||
Business and government |
– | – | ||||||||||||||||||||||||||||
Bank |
– | – | – | – | ||||||||||||||||||||||||||
Secured borrowings |
– | – | ( |
) | ||||||||||||||||||||||||||
Derivative instruments |
– | |
– | – | – | |||||||||||||||||||||||||
Acceptances |
– | – | – | – | ||||||||||||||||||||||||||
Obligations related to securities sold short |
– | – | – | – | ||||||||||||||||||||||||||
Cash collateral on securities lent |
– | – | – | – | ||||||||||||||||||||||||||
Obligations related to securities sold under repurchase agreements |
– | – | – | |||||||||||||||||||||||||||
Other liabilities |
– | – | ||||||||||||||||||||||||||||
Subordinated indebtedness | – | – | – |
CIBC 2024 |
|
131 |
Consolidated financial statements |
$ millions, as at October 31 | 2024 |
2023 | ||||||||||||||||||||||||
Positive |
Negative |
Net |
Positive | Negative | Net | |||||||||||||||||||||
Held for trading |
||||||||||||||||||||||||||
Interest rate derivatives |
||||||||||||||||||||||||||
Over-the-counter |
– Forward rate agreements |
$ |
$ |
$ |
( |
) |
$ |
$ |
$ |
|||||||||||||||||
– Swap contracts |
( |
) |
( |
) | ||||||||||||||||||||||
– Purchased options |
– |
– |
||||||||||||||||||||||||
– Written options |
– |
( |
) |
– |
( |
) | ||||||||||||||||||||
( |
) |
( |
) | |||||||||||||||||||||||
Exchange-traded |
– Futures contracts |
– |
– |
– |
– | – | – | |||||||||||||||||||
– Purchased options |
– |
– | ||||||||||||||||||||||||
– Written options |
– |
( |
) |
– |
( |
) | ||||||||||||||||||||
– |
– |
|||||||||||||||||||||||||
Total interest rate derivatives |
( |
) |
( |
) | ||||||||||||||||||||||
Foreign exchange derivatives |
||||||||||||||||||||||||||
Over-the-counter |
– Forward contracts |
|||||||||||||||||||||||||
– Swap contracts |
( |
) |
( |
) | ||||||||||||||||||||||
– Purchased options |
– |
– | ||||||||||||||||||||||||
– Written options |
– |
( |
) |
– |
( |
) | ||||||||||||||||||||
Total foreign exchange derivatives |
( |
) |
( |
) | ||||||||||||||||||||||
Credit derivatives |
||||||||||||||||||||||||||
Over-the-counter |
– Credit default swap contracts – protection purchased |
|||||||||||||||||||||||||
– Credit default swap contracts – protection sold |
– |
( |
) |
( |
) | |||||||||||||||||||||
Total credit derivatives |
( |
) |
||||||||||||||||||||||||
Equity derivatives |
||||||||||||||||||||||||||
Over-the-counter |
( |
) |
( |
) | ||||||||||||||||||||||
Exchange-traded |
( |
) | ||||||||||||||||||||||||
Total equity derivatives |
( |
) |
( |
) | ||||||||||||||||||||||
Precious metal and other commodity derivatives |
||||||||||||||||||||||||||
Over-the-counter |
( |
) |
||||||||||||||||||||||||
Exchange-traded |
( |
) | ||||||||||||||||||||||||
Total precious metal and other commodity derivatives |
( |
) |
||||||||||||||||||||||||
Total held for trading |
( |
) |
( |
) | ||||||||||||||||||||||
Held for ALM |
||||||||||||||||||||||||||
Interest rate derivatives |
||||||||||||||||||||||||||
Over-the-counter |
– Forward rate agreements |
– |
– |
– |
– | |||||||||||||||||||||
– Swap contracts |
( |
) |
( |
) | ||||||||||||||||||||||
– Purchased options |
– |
|||||||||||||||||||||||||
– Written options |
– |
( |
) |
– | ( |
) | ||||||||||||||||||||
Total interest rate derivatives |
( |
) |
( |
) | ||||||||||||||||||||||
Foreign exchange derivatives |
||||||||||||||||||||||||||
Over-the-counter |
– Forward contracts |
( |
) |
( |
) | |||||||||||||||||||||
– Swap contracts |
( |
) | ||||||||||||||||||||||||
Total foreign exchange derivatives |
( |
) | ||||||||||||||||||||||||
Equity derivatives |
||||||||||||||||||||||||||
Over-the-counter |
( |
) | ||||||||||||||||||||||||
Total equity derivatives |
( |
) | ||||||||||||||||||||||||
Precious metal and other commodity derivatives |
||||||||||||||||||||||||||
Over-the-counter |
– |
– | – | – | ||||||||||||||||||||||
Total precious metal and other commodity derivatives |
– |
– | – | – | ||||||||||||||||||||||
Total held for ALM |
||||||||||||||||||||||||||
Total fair value |
( |
) |
( |
) | ||||||||||||||||||||||
Less: effect of netting |
( |
) |
( |
) |
– |
( |
) | ( |
) | – | ||||||||||||||||
$ |
$ |
$ |
( |
) |
$ | $ | $ | ( |
) |
Level 1 |
Level 2 |
Level 3 |
||||||||||||||||||||||||||||||||||||||||||
Quoted market price |
Valuation technique – observable market inputs |
Valuation technique – non-observable market inputs |
Total 2024 |
Total 2023 |
||||||||||||||||||||||||||||||||||||||||
$ millions, as at October 31 |
2024 |
2023 |
2024 |
2023 |
2024 |
2023 |
||||||||||||||||||||||||||||||||||||||
Financial assets |
||||||||||||||||||||||||||||||||||||||||||||
Amortized cost securities |
$ |
– |
$ |
– |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||||||||||||||||||
Loans |
||||||||||||||||||||||||||||||||||||||||||||
Residential mortgages |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||
Personal |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||
Credit card |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||
Business and government |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||
Financial liabilities |
||||||||||||||||||||||||||||||||||||||||||||
Deposits |
||||||||||||||||||||||||||||||||||||||||||||
Personal |
$ |
– |
$ |
– |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||||||||||||||||||
Business and government |
– |
– |
||||||||||||||||||||||||||||||||||||||||||
Bank |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||
Secured borrowings |
– |
– |
||||||||||||||||||||||||||||||||||||||||||
Subordinated indebtedness |
– |
– |
– |
– |
132 |
CIBC 2024 |
Consolidated financial statements |
Level 1 |
Level 2 |
Level 3 |
||||||||||||||||||||||||||||||||||||||||||
Quoted market price |
Valuation technique – observable market inputs |
Valuation technique – non-observable market inputs |
Total 2024 |
Total 2023 |
||||||||||||||||||||||||||||||||||||||||
$ millions, as at October 31 |
2024 |
2023 |
2024 |
2023 |
2024 |
2023 |
||||||||||||||||||||||||||||||||||||||
Financial assets |
||||||||||||||||||||||||||||||||||||||||||||
Debt securities measured at FVTPL |
||||||||||||||||||||||||||||||||||||||||||||
Government issued or guaranteed |
$ |
$ |
$ |
$ |
$ |
– |
$ |
– |
$ |
$ |
||||||||||||||||||||||||||||||||||
Corporate debt |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||
Mortgage- and asset-backed |
– |
– |
||||||||||||||||||||||||||||||||||||||||||
Loans measured at FVTPL |
||||||||||||||||||||||||||||||||||||||||||||
Business and government |
– |
– |
(1) |
(1) |
||||||||||||||||||||||||||||||||||||||||
Residential mortgages |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||
– |
– |
|||||||||||||||||||||||||||||||||||||||||||
Debt securities measured at FVOCI |
||||||||||||||||||||||||||||||||||||||||||||
Government issued or guaranteed |
– |
– |
||||||||||||||||||||||||||||||||||||||||||
Corporate debt |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||
Mortgage- and asset-backed |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||
– |
– |
|||||||||||||||||||||||||||||||||||||||||||
Corporate equity mandatorily measured at FVTPL and designated at FVOCI |
||||||||||||||||||||||||||||||||||||||||||||
Securities purchased under resale agreements measured at FVTPL |
– |
– |
(2) |
– |
– |
|||||||||||||||||||||||||||||||||||||||
Other assets |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||
Derivative instruments |
||||||||||||||||||||||||||||||||||||||||||||
Interest rate |
||||||||||||||||||||||||||||||||||||||||||||
Foreign exchange |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||
Credit |
– |
– |
||||||||||||||||||||||||||||||||||||||||||
Equity |
||||||||||||||||||||||||||||||||||||||||||||
Precious metal and other commodity |
– |
– |
||||||||||||||||||||||||||||||||||||||||||
Total financial assets |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||||||||||||||||||||
Financial liabilities |
||||||||||||||||||||||||||||||||||||||||||||
Deposits and other liabilities (3) |
$ |
– |
$ |
– |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | ||||||||||||||||||||||
Obligations related to securities sold short |
( |
) |
( |
) |
( |
) |
( |
) |
– |
– |
( |
) |
( |
) | ||||||||||||||||||||||||||||||
Obligations related to securities sold under repurchase agreements |
– |
– |
( |
) |
( |
) |
– |
– |
( |
) |
( |
) | ||||||||||||||||||||||||||||||||
Derivative instruments |
||||||||||||||||||||||||||||||||||||||||||||
Interest rate |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||||||||||
Foreign exchange |
– |
– |
( |
) |
( |
) |
( |
) |
– |
( |
) |
( |
) | |||||||||||||||||||||||||||||||
Credit |
– |
– |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||||||||||||
Equity |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||||||||||
Precious metal and other commodity |
( |
) |
( |
) |
( |
) |
( |
) |
– |
– |
( |
) |
( |
) | ||||||||||||||||||||||||||||||
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | |||||||||||||||||||||||||||||
Total financial liabilities |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
(1) | Relates to loans designated at FVTPL. |
(2) | The disclosed amount has been restated with no impact on the measurement of the related financial instruments in the consolidated financial statements. |
(3) | Comprises deposits designated at FVTPL of $ |
CIBC 2024 |
|
133 |
Consolidated financial statements |
Net gains (losses) included in income (1) |
||||||||||||||||||||||||||||||||||||
$ millions, for the year ended October 31 |
Opening balance |
Realized | Unrealized (2) |
Net gains (losses) included in OCI (3) |
Transfer in to Level 3 |
Transfer out of Level 3 |
Purchases/ Issuances |
Sales/ Settlements |
Closing balance |
|||||||||||||||||||||||||||
2024 |
||||||||||||||||||||||||||||||||||||
Debt securities measured at FVTPL |
||||||||||||||||||||||||||||||||||||
Corporate debt |
$ |
– |
$ |
– |
$ |
– |
$ |
– |
$ |
– |
$ |
– |
$ |
– |
$ |
– |
$ |
– |
||||||||||||||||||
Mortgage- and asset-backed |
– |
( |
) |
– |
– |
– |
( |
) |
||||||||||||||||||||||||||||
Loans measured at FVTPL |
||||||||||||||||||||||||||||||||||||
Business and government |
– |
– |
– |
– |
– |
( |
) |
|||||||||||||||||||||||||||||
Corporate equity mandatorily measured at |
||||||||||||||||||||||||||||||||||||
FVTPL and designated at FVOCI |
( |
) |
– |
– |
( |
) |
||||||||||||||||||||||||||||||
Derivative instruments |
||||||||||||||||||||||||||||||||||||
Interest rate |
– |
– |
– |
( |
) |
– |
– |
|||||||||||||||||||||||||||||
Foreign exchange |
– |
– |
– |
– |
– |
– |
– |
– |
– |
|||||||||||||||||||||||||||
Credit |
( |
) |
– |
– |
– |
– |
||||||||||||||||||||||||||||||
Equity |
– |
– |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
Total assets |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
|||||||||||||||||||||
Deposits and other liabilities (4) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
– |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
( |
) | ||||||||||||||
Derivative instruments |
||||||||||||||||||||||||||||||||||||
Interest rate |
( |
) |
– |
– |
– |
( |
) |
( |
) | |||||||||||||||||||||||||||
Foreign exchange |
– |
– |
( |
) |
– |
– |
– |
– |
( |
) | ||||||||||||||||||||||||||
Credit |
( |
) |
– |
( |
) |
– |
– |
( |
) | |||||||||||||||||||||||||||
Equity |
( |
) |
– |
( |
) |
– |
( |
) |
– |
( |
) | |||||||||||||||||||||||||
Total liabilities |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
– |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
( |
) | ||||||||||||||||
2023 |
||||||||||||||||||||||||||||||||||||
Debt securities measured at FVTPL |
||||||||||||||||||||||||||||||||||||
Corporate debt |
$ |
$ |
– |
$ |
– |
$ |
– |
$ |
– |
$ |
– |
$ |
– |
$ |
( |
) |
$ |
– |
||||||||||||||||||
Mortgage- and asset-backed |
– |
– |
– |
– |
– |
( |
) |
|||||||||||||||||||||||||||||
Loans measured at FVTPL |
||||||||||||||||||||||||||||||||||||
Business and government |
– |
( |
) |
– |
– |
– |
( |
) |
||||||||||||||||||||||||||||
Corporate equity mandatorily measured at |
||||||||||||||||||||||||||||||||||||
FVTPL and designated at FVOCI |
– |
– |
( |
) |
||||||||||||||||||||||||||||||||
Derivative instruments |
||||||||||||||||||||||||||||||||||||
Interest rate |
– |
– |
– |
– |
( |
) |
||||||||||||||||||||||||||||||
Foreign exchange |
– |
– |
– |
– |
( |
) |
– |
– |
– |
|||||||||||||||||||||||||||
Credit |
( |
) |
– |
– |
– |
– |
( |
) |
||||||||||||||||||||||||||||
Equity |
– |
– |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
Total assets |
$ |
$ |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
|||||||||||||||||||||||
Deposits and other liabilities (4) |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
– |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
( |
) | ||||||||||||||||
Derivative instruments |
||||||||||||||||||||||||||||||||||||
Interest rate |
( |
) |
– |
( |
) |
– |
– |
( |
) |
( |
) | |||||||||||||||||||||||||
Foreign exchange |
– |
– |
– |
– |
– |
– |
– |
– |
– |
|||||||||||||||||||||||||||
Credit |
( |
) |
( |
) |
– |
– |
– |
– |
– |
( |
) | |||||||||||||||||||||||||
Equity |
( |
) |
– |
( |
) |
– |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||||||
Total liabilities |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
– |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
(1) | Cumulative AOCI gains or losses related to equity securities designated at FVOCI are reclassified from AOCI to retained earnings at the time of disposal or derecognition. |
(2) | Comprises unrealized gains and losses relating to these assets and liabilities held at the end of the reporting year. |
(3) | Foreign exchange translation on loans measured at FVTPL held by foreign operations and denominated in the same currency as the foreign operations is included in OCI. |
(4) | Includes deposits designated at FVTPL of $ |
134 |
CIBC 2024 |
Consolidated financial statements |
Range of inputs |
||||||||||||||||||||||||
$ millions, as at October 31 |
2024 |
Valuation techniques |
Key non-observable inputs |
Low |
High |
|||||||||||||||||||
Debt securities measured at FVTPL |
||||||||||||||||||||||||
Mortgage- and asset-backed |
$ |
Discounted cash flow | Credit spread | % | % | |||||||||||||||||||
Corporate equity mandatorily measured at FVTPL and designated at FVOCI |
||||||||||||||||||||||||
Limited partnerships and private companies |
Adjusted net asset value | (1) |
Net asset value | (2) |
n/a | n/a | ||||||||||||||||||
Valuation multiple | Earnings multiple | x | x | |||||||||||||||||||||
Proxy share price | Proxy share price | (2) |
n/a | n/a | ||||||||||||||||||||
Loans measured at FVTPL Business and government |
Discounted cash flow | Credit spread | % | % | ||||||||||||||||||||
Derivative instruments |
||||||||||||||||||||||||
Interest rate |
Proprietary model | (3) |
n/a | n/a | n/a | |||||||||||||||||||
Option model | Market volatility | % | % | |||||||||||||||||||||
Probability of contingent settlement | % | % | ||||||||||||||||||||||
Credit |
Market proxy or direct broker quote | Market proxy or direct broker quote | % | % | ||||||||||||||||||||
Equity |
Option model | Market correlation | % | % | ||||||||||||||||||||
Total assets |
$ |
|||||||||||||||||||||||
Deposits and other liabilities |
||||||||||||||||||||||||
Deposits designated at FVTPL and net bifurcated embedded derivative liabilities |
$ |
( |
) |
Option model | Market volatility | % | % | |||||||||||||||||
Market correlation | ( |
)% | % | |||||||||||||||||||||
Other liabilities designated at FVTPL |
( |
) |
Option model | Funding ratio | % | % | ||||||||||||||||||
Derivative instruments |
||||||||||||||||||||||||
Interest rate |
( |
) |
Proprietary model | (3) |
n/a | n/a | n/a | |||||||||||||||||
Option model | Market volatility | % | % | |||||||||||||||||||||
Probability of contingent settlement | % | % | ||||||||||||||||||||||
Foreign exchange |
( |
) |
Option model | Probability of contingent settlement | % | % | ||||||||||||||||||
Credit |
( |
) |
Market proxy or direct broker quote | Market proxy or direct broker quote | % | % | ||||||||||||||||||
Equity |
( |
) |
Option model | Market correlation | % | % | ||||||||||||||||||
Total liabilities |
$ |
( |
) |
(1) | Adjusted net asset value is determined using reported net asset values obtained from the fund manager or general partner of the limited partnership or the limited liability company and may be adjusted for current market levels where appropriate. |
(2) | The range of net asset value price or proxy share price has not been disclosed due to the wide range and diverse nature of the investments. |
(3) | Using valuation techniques that we consider to be non-observable. |
n/a | Not applicable. |
CIBC 2024 |
|
135 |
Consolidated financial statements |
• | Certain business and government deposit liabilities, certain secured borrowings and certain obligations related to securities sold under repurchase agreements that are economically hedged with derivatives and other financial instruments, and certain financial liabilities that have one or more embedded derivatives that significantly modify the cash flows of the host liability but are not bifurcated from the host instrument; and |
• | Our mortgage commitments to retail clients to provide mortgages at fixed rates that are economically hedged with derivatives and other financial instruments. |
Note 3 |
Significant transactions |
136 |
CIBC 2024 |
Consolidated financial statements |
Note 4 |
Securities |
$ millions, as at October 31 |
2024 |
2023 |
||||||
Securities measured and designated at FVOCI |
$ |
$ | ||||||
Securities measured at amortized cost (1) |
||||||||
Securities mandatorily measured and designated at FVTPL |
||||||||
$ |
$ | |
(1) | During the year, less than $ |
Residual term to contractual maturity |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
$ millions, as at October 31 |
Within 1 year |
1 to 5 years |
5 to 10 years |
Over 10 years |
No specific maturity |
2024 Total |
2023 Total |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carrying value |
Yield (1) |
Carrying value |
Yield (1) |
Carrying value |
Yield (1) |
Carrying value |
Yield (1) |
Carrying value |
Yield (1) |
Carrying value |
Yield (1) |
Carrying value |
Yield (1) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt securities measured at FVOCI |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Securities issued or guaranteed by: |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Canadian federal government |
$ |
% |
$ |
% |
$ |
% |
$ |
– |
– |
% |
$ |
– |
– |
% |
$ |
% |
$ |
% |
||||||||||||||||||||||||||||||||||||||||||||||||||
Other Canadian governments |
– |
– |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
U.S. Treasury and agencies |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other foreign governments |
– |
– |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mortgage-backed securities (2) |
– |
– |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Asset-backed securities |
– |
– |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Corporate debt |
– |
– |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
$ |
$ |
$ |
$ |
$ |
– |
$ |
$ |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Securities measured at amortized cost |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Securities issued or guaranteed by: |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Canadian federal government |
$ |
% |
$ |
% |
$ |
% |
$ |
– |
– |
% |
$ |
– |
– |
% |
$ |
% |
$ |
% |
||||||||||||||||||||||||||||||||||||||||||||||||||
Other Canadian governments |
– |
– |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
U.S. Treasury and agencies |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other foreign governments |
– |
– |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mortgage-backed securities (3) |
– |
– |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Asset-backed securities |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Corporate debt |
– |
– |
– |
– |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
$ |
$ |
$ |
$ |
$ |
– |
$ |
$ |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt securities mandatorily measured and designated at FVTPL |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Securities issued or guaranteed by: |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Canadian federal government |
$ |
$ |
$ |
$ |
$ |
– |
$ |
$ |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Canadian governments |
– |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
U.S. Treasury and agencies |
– |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other foreign governments |
– |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mortgage-backed securities (4) |
– |
– |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Asset-backed securities |
– |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Corporate debt |
– |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
$ |
$ |
$ |
$ |
$ |
– |
$ |
$ |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Corporate equity mandatorily measured at FVTPL and designated at FVOCI |
$ |
– |
– |
% |
$ |
– |
– |
% |
$ |
– |
– |
% |
$ |
– |
– |
% |
$ |
n/m |
$ |
n/m |
$ |
n/m |
||||||||||||||||||||||||||||||||||||||||||||||
Total securities (5) |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
(1) | Represents the weighted-average yield, which is determined by applying the weighted average of the yields of individual fixed income securities. |
(2) | Includes securities backed by mortgages insured by the Canada Mortgage and Housing Corporation (CMHC), with amortized cost of $ |
(3) | Includes securities backed by mortgages insured by the CMHC, with amortized cost of $ |
(4) | Includes securities backed by mortgages insured by the CMHC of $ |
(5) | Includes securities denominated in U.S. dollars with carrying value of $ |
n/m | Not meaningful. |
CIBC 2024 |
|
137 |
Consolidated financial statements |
$ millions, as at October 31 |
2024 |
2023 |
||||||||||||||||||||||||||||||||||
Cost/ Amortized cost (1) |
Gross unrealized gains |
Gross unrealized losses |
Fair value |
Cost/ Amortized cost (1) |
Gross unrealized gains |
Gross unrealized losses |
Fair value |
|||||||||||||||||||||||||||||
Securities issued or guaranteed by: |
||||||||||||||||||||||||||||||||||||
Canadian federal government |
$ |
$ |
$ |
( |
) |
$ |
$ | $ | $ | ( |
) | $ | ||||||||||||||||||||||||
Other Canadian governments |
( |
) |
( |
) | ||||||||||||||||||||||||||||||||
U.S. Treasury and agencies |
( |
) |
( |
) | ||||||||||||||||||||||||||||||||
Other foreign governments |
( |
) |
( |
) | ||||||||||||||||||||||||||||||||
Mortgage-backed securities |
– |
( |
) |
– | ( |
) | ||||||||||||||||||||||||||||||
Asset-backed securities |
– |
– | ( |
) | ||||||||||||||||||||||||||||||||
Corporate debt |
( |
) |
( |
) | ||||||||||||||||||||||||||||||||
( |
) |
( |
) | |||||||||||||||||||||||||||||||||
Corporate equity (2) |
( |
) |
( |
) | ||||||||||||||||||||||||||||||||
$ |
$ |
$ |
( |
) |
$ |
$ | |
$ | |
$ | ( |
) | $ | |
(1) | Net of allowance for credit losses for debt securities measured at FVOCI of $ |
(2) | Includes restricted stock. |
$ millions, for the year ended October 31 |
2024 |
2023 |
||||||
Realized gains |
$ |
$ | |
|||||
Realized losses |
( |
) |
( |
) | ||||
(Provision for) reversal of credit losses on debt securities |
||||||||
$ |
$ |
Stage 1 |
Stage 2 |
Stage 3 |
||||||||||||||||
$ millions, as at or for the year ended October 31 |
Collective provision 12-month ECL performing |
Collective provision lifetime ECL performing |
Collective and individual provision lifetime ECL credit-impaired (1) |
Total |
||||||||||||||
2024 |
Debt securities measured at FVOCI and amortized cost |
|||||||||||||||||
Balance at beginning of year |
$ |
$ |
$ |
$ |
||||||||||||||
Reversal of credit losses (2) |
– |
( |
) |
( |
) |
( |
) | |||||||||||
Write-offs |
– |
– |
– |
– |
||||||||||||||
Foreign exchange and other |
( |
) |
– |
– |
( |
) | ||||||||||||
Balance at end of year | $ |
$ |
$ |
$ |
||||||||||||||
Comprises: |
||||||||||||||||||
Debt securities measured at FVOCI |
$ |
$ |
$ |
– |
$ |
|||||||||||||
Debt securities measured at amortized cost |
– |
|||||||||||||||||
2023 | Debt securities measured at FVOCI and amortized cost |
|||||||||||||||||
Balance at beginning of year |
$ | $ | $ | $ | ||||||||||||||
Provision for credit losses (2) |
– | |||||||||||||||||
Write-offs |
– | – | – | – | ||||||||||||||
Foreign exchange and other |
( |
) | – | – | ||||||||||||||
Balance at end of year | $ | $ | $ | $ | ||||||||||||||
Comprises: |
||||||||||||||||||
Debt securities measured at FVOCI |
$ | $ | $ | – | $ | |||||||||||||
Debt securities measured at amortized cost |
– |
(1) | Includes stage 3 ECL allowance on originated credit-impaired amortized cost debt securities. |
(2) | Included in Gains (losses) from debt securities measured at FVOCI and amortized cost, net on our consolidated statement of income . |
Note 5 |
Loans (1)(2) |
$ millions, as at October 31 |
2024 |
2023 |
||||||||||||||||||||||||||||||||||||||||||||||||||
Gross amount |
Stage 3 allowance |
Stages 1 and 2 allowance |
Total allowance (3) |
Net total |
Allowances as a % of gross loans |
Gross amount |
Stage 3 allowance |
Stages 1 and 2 allowance |
Total allowance (3) |
Net total |
Allowances as a % of gross loans |
|||||||||||||||||||||||||||||||||||||||||
Residential mortgages (4) |
$ |
$ |
$ |
$ |
$ |
% |
$ |
$ |
$ |
$ |
$ |
% | ||||||||||||||||||||||||||||||||||||||||
Personal |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Credit card |
– |
– |
||||||||||||||||||||||||||||||||||||||||||||||||||
Business and government (4) |
||||||||||||||||||||||||||||||||||||||||||||||||||||
$ |
$ |
$ |
$ |
$ |
% |
$ |
$ |
$ |
$ |
$ |
% |
(1) | Loans are net of unearned income of $ |
(2) | Includes gross loans of $ |
(3) | Includes ECL allowances for customers’ liability under acceptances. |
(4) | Includes $ |
138 |
CIBC 2024 |
Consolidated financial statements |
$ millions, as at or for the year ended October 31 | 2024 |
|||||||||||||||
Stage 1 |
Stage 2 |
Stage 3 |
||||||||||||||
Collective provision 12-month ECL performing |
Collective provision lifetime ECL performing |
Collective and individual provision lifetime ECL credit-impaired |
Total |
|||||||||||||
Residential mortgages |
||||||||||||||||
Balance at beginning of year |
$ |
$ |
$ |
$ |
||||||||||||
Provision for (reversal of) credit losses |
||||||||||||||||
Originations net of repayments and other derecognitions (1) |
( |
) |
( |
) |
( |
) | ||||||||||
Changes in model |
– |
|||||||||||||||
Net remeasurement (2) |
( |
) |
||||||||||||||
Transfers (2) |
||||||||||||||||
– to 12-month ECL |
( |
) |
( |
) |
– |
|||||||||||
– to lifetime ECL performing |
( |
) |
( |
) |
– |
|||||||||||
– to lifetime ECL credit-impaired |
– |
( |
) |
– |
||||||||||||
Total provision for (reversal of) credit losses (3) |
( |
) |
( |
) |
||||||||||||
Write-offs (4) |
– |
– |
( |
) |
( |
) | ||||||||||
Recoveries |
– |
– |
||||||||||||||
Interest income on impaired loans |
– |
– |
( |
) |
( |
) | ||||||||||
Foreign exchange and other |
– |
( |
) |
|||||||||||||
Balance at end of year |
$ |
$ |
$ |
$ |
||||||||||||
Personal |
||||||||||||||||
Balance at beginning of year |
$ |
$ |
$ |
$ |
||||||||||||
Provision for (reversal of) credit losses |
||||||||||||||||
Originations net of repayments and other derecognitions (1) |
( |
) |
( |
) |
( |
) | ||||||||||
Changes in model |
( |
) |
( |
) |
( |
) | ||||||||||
Net remeasurement (2) |
( |
) |
||||||||||||||
Transfers (2) |
||||||||||||||||
– to 12-month ECL |
( |
) |
( |
) |
– |
|||||||||||
– to lifetime ECL performing |
( |
) |
( |
) |
– |
|||||||||||
– to lifetime ECL credit-impaired |
– |
( |
) |
– |
||||||||||||
Total provision for (reversal of) credit losses (3) |
( |
) |
||||||||||||||
Write-offs (4) |
– |
– |
( |
) |
( |
) | ||||||||||
Recoveries |
– |
– |
||||||||||||||
Interest income on impaired loans |
– |
– |
( |
) |
( |
) | ||||||||||
Foreign exchange and other |
( |
) |
||||||||||||||
Balance at end of year |
$ |
$ |
$ |
$ |
||||||||||||
Credit card |
||||||||||||||||
Balance at beginning of year |
$ |
$ |
$ |
– |
$ |
|||||||||||
Provision for (reversal of) credit losses |
||||||||||||||||
Originations net of repayments and other derecognitions (1) |
( |
) |
– |
( |
) | |||||||||||
Changes in model |
( |
) |
– |
|||||||||||||
Net remeasurement (2) |
( |
) |
||||||||||||||
Transfers (2) |
||||||||||||||||
– to 12-month ECL |
( |
) |
– |
– |
||||||||||||
– to lifetime ECL performing |
( |
) |
– |
– |
||||||||||||
– to lifetime ECL credit-impaired |
– |
( |
) |
– |
||||||||||||
Total provision for (reversal of) credit losses (3) |
||||||||||||||||
Write-offs (4) |
– |
– |
( |
) |
( |
) | ||||||||||
Recoveries |
– |
– |
||||||||||||||
Interest income on impaired loans |
– |
– |
– |
– |
||||||||||||
Foreign exchange and other |
– |
– |
– |
– |
||||||||||||
Balance at end of year |
$ |
$ |
$ |
– |
$ |
|||||||||||
Business and government |
||||||||||||||||
Balance at beginning of year |
$ |
$ |
$ |
$ |
||||||||||||
Provision for (reversal of) credit losses |
||||||||||||||||
Originations net of repayments and other derecognitions (1) |
( |
) |
( |
) |
( |
) | ||||||||||
Changes in model |
( |
) |
– |
|||||||||||||
Net remeasurement (2) |
( |
) |
||||||||||||||
Transfers (2) |
||||||||||||||||
– to 12-month ECL |
( |
) |
( |
) |
– |
|||||||||||
– to lifetime ECL performing |
( |
) |
( |
) |
– |
|||||||||||
– to lifetime ECL credit-impaired |
– |
( |
) |
– |
||||||||||||
Total provision for (reversal of) credit losses (3) |
( |
) |
||||||||||||||
Write-offs (4) |
– |
– |
( |
) |
( |
) | ||||||||||
Recoveries |
– |
– |
||||||||||||||
Interest income on impaired loans |
– |
– |
( |
) |
( |
) | ||||||||||
Foreign exchange and other |
( |
) |
||||||||||||||
Balance at end of year |
$ |
$ |
$ |
$ |
||||||||||||
Total ECL allowance (5) |
$ |
$ |
$ |
$ |
||||||||||||
Comprises: |
||||||||||||||||
Loans |
$ |
$ |
$ |
$ |
||||||||||||
Undrawn credit facilities and other off-balance sheet exposures (6) |
(1) |
Excludes the disposal and write-off of impaired loans. |
(2) |
Transfers represent stage movements of ECL allowances before net remeasurement. Net remeasurement represents the current period change in ECL allowances for transfers, net write-offs, changes in forecasts of forward-looking information, parameter updates, and partial repayments in the year. |
(3) |
Provision for (reversal of) credit losses for loans, and undrawn credit facilities and other off-balance sheet exposures is presented as Provision for (reversal of) credit losses on our consolidated statement of income. |
(4) |
We generally continue to pursue collection on the amounts that were written off. The degree of collection efforts varies from one jurisdiction to another, depending on the local regulations and original agreements with customers. |
(5) |
See Note 4 for the ECL allowance on debt securities measured at FVOCI and amortized cost. The ECL allowances for other financial assets classified at amortized cost were immaterial as at October 31, 2024 and October 31, 2023 and were excluded from the table above. Financial assets other than loans that are classified at amortized cost are presented on our consolidated balance sheet net of ECL allowances. |
(6) |
Included in Other liabilities on our consolidated balance sheet. |
(7) |
Includes the impact of a change in the internal risk rating methodology applied in the first quarter of 2023 at CIBC Bank USA. |
CIBC 2024 |
|
139 |
Consolidated financial statements |
$ millions, as at or for the year ended October 31 |
2023 | |||||||||||||||||||
Stage 1 | Stage 2 | Stage 3 | ||||||||||||||||||
Collective provision 12-month ECL performing |
Collective provision lifetime ECL performing |
Collective and individual provision lifetime ECL credit-impaired |
Total | |||||||||||||||||
Residential mortgages |
||||||||||||||||||||
Balance at beginning of year |
$ | $ | $ | $ | ||||||||||||||||
Provision for (reversal of) credit losses |
||||||||||||||||||||
Originations net of repayments and other derecognitions (1) |
( |
) | ( |
) | ( |
) | ||||||||||||||
Changes in model |
||||||||||||||||||||
Net remeasurement ( 2 ) |
( |
) | ||||||||||||||||||
Transfers ( 2 ) |
||||||||||||||||||||
– to 12-month ECL |
( |
) | ( |
) | – | |||||||||||||||
– to lifetime ECL performing |
( |
) | ( |
) | – | |||||||||||||||
– to lifetime ECL credit-impaired |
– | ( |
) | – | ||||||||||||||||
Total provision for (reversal of) credit losses (3) |
||||||||||||||||||||
Write-offs ( 4 ) |
– | – | ( |
) | ( |
) | ||||||||||||||
Recoveries |
– | – | ||||||||||||||||||
Interest income on impaired loans |
– | – | ( |
) | ( |
) | ||||||||||||||
Foreign exchange and other |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
Balance at end of year |
$ | $ | $ | $ | ||||||||||||||||
Personal |
||||||||||||||||||||
Balance at beginning of year |
$ | $ | $ | $ | ||||||||||||||||
Provision for (reversal of) credit losses |
||||||||||||||||||||
Originations net of repayments and other derecognitions (1) |
( |
) | ( |
) | ( |
) | ||||||||||||||
Changes in model |
( |
) | – | – | ( |
) | ||||||||||||||
Net remeasurement ( 2 ) |
( |
) | ||||||||||||||||||
Transfers ( 2 ) |
||||||||||||||||||||
– to 12-month ECL |
( |
) | ( |
) | – | |||||||||||||||
– to lifetime ECL performing |
( |
) | ( |
) | – | |||||||||||||||
– to lifetime ECL credit-impaired |
– | ( |
) | – | ||||||||||||||||
Total provision for (reversal of) credit losses (3) |
||||||||||||||||||||
Write-offs ( 4 ) |
– | – | ( |
) | ( |
) | ||||||||||||||
Recoveries |
– | – | ||||||||||||||||||
Interest income on impaired loans |
– | – | ( |
) | ( |
) | ||||||||||||||
Foreign exchange and other |
( |
) | ||||||||||||||||||
Balance at end of year |
$ | $ | $ | $ | ||||||||||||||||
Credit card |
||||||||||||||||||||
Balance at beginning of year |
$ | $ | $ | – | $ | |||||||||||||||
Provision for (reversal of) credit losses |
||||||||||||||||||||
Originations net of repayments and other derecognitions (1) |
( |
) | – | ( |
) | |||||||||||||||
Changes in model |
– | – | – | – | ||||||||||||||||
Net remeasurement ( 2 ) |
( |
) | ||||||||||||||||||
Transfers ( 2 ) |
||||||||||||||||||||
– to 12-month ECL |
( |
) | – | – | ||||||||||||||||
– to lifetime ECL performing |
( |
) | – | – | ||||||||||||||||
– to lifetime ECL credit-impaired |
– | ( |
) | – | ||||||||||||||||
Total provision for (reversal of) credit losses ( 3 ) |
( |
) | ||||||||||||||||||
Write-offs ( 4 ) |
– | – | ( |
) | ( |
) | ||||||||||||||
Recoveries |
– | – | ||||||||||||||||||
Interest income on impaired loans |
– | – | – | – | ||||||||||||||||
Foreign exchange and other |
– | – | – | – | ||||||||||||||||
Balance at end of year |
$ | $ | $ | – | $ | |||||||||||||||
Business and government |
||||||||||||||||||||
Balance at beginning of year |
$ | $ | $ | $ | ||||||||||||||||
Provision for (reversal of) credit losses |
||||||||||||||||||||
Originations net of repayments and other derecognitions (1) |
( |
) | ( |
) | ( |
) | ||||||||||||||
Changes in model |
( |
) | – | |||||||||||||||||
Net remeasurement ( 2 )(7 ) |
( |
) | ||||||||||||||||||
Transfers ( 2 ) |
||||||||||||||||||||
– to 12-month ECL |
( |
) | ( |
) | – | |||||||||||||||
– to lifetime ECL performing |
( |
) | ( |
) | – | |||||||||||||||
– to lifetime ECL credit-impaired |
– | ( |
) | – | ||||||||||||||||
Total provision for (reversal of) credit losses ( 3 ) |
( |
) | ||||||||||||||||||
Write-offs ( 4 ) |
– | – | ( |
) | ( |
) | ||||||||||||||
Recoveries |
– | – | ||||||||||||||||||
Interest income on impaired loans |
– | – | ( |
) | ( |
) | ||||||||||||||
Foreign exchange and other |
||||||||||||||||||||
Balance at end of year |
$ | $ | $ | $ | ||||||||||||||||
Total ECL allowance 5 ) |
$ | $ | $ | $ | ||||||||||||||||
Comprises: |
||||||||||||||||||||
Loans |
$ | |
$ | |
$ | |
$ | |
||||||||||||
Undrawn credit facilities and other off-balance sheet exposures ( 6 ) |
– |
140 |
CIBC 2024 |
Consolidated financial statements |
• | Determining when a SICR of a loan has occurred; |
• | Measuring both 12-month and lifetime credit losses; and |
• | Forecasting forward-looking information for multiple scenarios and determining the probability weighting of the scenarios driven by the changes in the macroeconomic environment. |
CIBC 2024 |
|
141 |
Consolidated financial statements |
Base case | Upside case | Downside case | ||||||||||||||||||||||
As at October 31, 2024 |
Average value over the next 12 months |
Average value over the remaining forecast period (1) |
Average value over the next 12 months |
Average value over the remaining forecast period (1) |
Average value over the next 12 months |
Average value over the remaining forecast period (1) |
||||||||||||||||||
Real GDP year-over-year growth |
||||||||||||||||||||||||
Canada (2) |
% |
% |
% |
% |
% |
% | ||||||||||||||||||
United States |
% |
% |
% |
% |
% |
% | ||||||||||||||||||
Unemployment rate |
||||||||||||||||||||||||
Canada (2) |
% |
% |
% |
% |
% |
% | ||||||||||||||||||
United States |
% |
% |
% |
% |
% |
% | ||||||||||||||||||
Canadian Housing Price Index growth (2) |
% |
% |
% |
% |
( |
)% |
% | |||||||||||||||||
Canadian household debt service ratio |
% |
% |
% |
% |
% |
% | ||||||||||||||||||
West Texas Intermediate Oil Price (US$) |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||
As at October 31, 2023 |
||||||||||||||||||||||||
Real GDP year-over-year growth |
||||||||||||||||||||||||
Canada (2) |
% | % | % | % | ( |
)% | % | |||||||||||||||||
United States |
% | % | % | % | ( |
)% | % | |||||||||||||||||
Unemployment rate |
||||||||||||||||||||||||
Canada (2) |
% | % | % | % | % | % | ||||||||||||||||||
United States |
% | % | % | % | % | % | ||||||||||||||||||
Canadian Housing Price Index growth (2) |
% | % | % | % | ( |
)% | % | |||||||||||||||||
Canadian household debt service ratio |
% | % | % | % | % | % | ||||||||||||||||||
West Texas Intermediate Oil Price (US$) |
$ | $ | $ | $ | $ | $ |
(1) | The remaining forecast period is generally four years. |
(2) | National-level forward-looking forecasts are presented in the table above, which represent the aggregation of the provincial-level forecasts used to estimate our ECL. Housing Price Index growth rates are also forecasted at the municipal level in some cases. As a result, the forecasts for individual provinces or municipalities reflected in our ECL will differ from the national forecasts presented above. |
142 |
CIBC 2024 |
Consolidated financial statements |
$ millions, as at October 31 |
2024 |
2023 | ||||||||||||||||||||||||||||||
Stage 1 |
Stage 2 |
Stage 3 (2)(3) |
Total |
Stage 1 | Stage 2 | Stage 3 (2)(3) |
Total | |||||||||||||||||||||||||
Residential mortgages |
||||||||||||||||||||||||||||||||
– Exceptionally low |
$ |
$ |
$ |
– |
$ |
$ | |
$ | |
$ | – | $ | |
|||||||||||||||||||
– Very low |
– |
– | ||||||||||||||||||||||||||||||
– Low |
– |
– | ||||||||||||||||||||||||||||||
– Medium |
– |
– | ||||||||||||||||||||||||||||||
– High |
– |
– | – | |||||||||||||||||||||||||||||
– Default |
– |
– |
– | – | ||||||||||||||||||||||||||||
– Not rated |
||||||||||||||||||||||||||||||||
Gross residential mortgages (4)(5) |
||||||||||||||||||||||||||||||||
ECL allowance |
||||||||||||||||||||||||||||||||
Net residential mortgages |
||||||||||||||||||||||||||||||||
Personal |
||||||||||||||||||||||||||||||||
– Exceptionally low |
– |
– | ||||||||||||||||||||||||||||||
– Very low |
– |
– | ||||||||||||||||||||||||||||||
– Low |
– |
– | ||||||||||||||||||||||||||||||
– Medium |
– |
– | ||||||||||||||||||||||||||||||
– High |
– |
– | ||||||||||||||||||||||||||||||
– Default |
– |
– |
– | – | ||||||||||||||||||||||||||||
– Not rated |
||||||||||||||||||||||||||||||||
Gross personal (5) |
||||||||||||||||||||||||||||||||
ECL allowance |
||||||||||||||||||||||||||||||||
Net personal |
||||||||||||||||||||||||||||||||
Credit card |
||||||||||||||||||||||||||||||||
– Exceptionally low |
– |
– |
– | – | ||||||||||||||||||||||||||||
– Very low |
– |
– |
– | – | ||||||||||||||||||||||||||||
– Low |
– |
– | ||||||||||||||||||||||||||||||
– Medium |
– |
– | ||||||||||||||||||||||||||||||
– High |
– |
– | ||||||||||||||||||||||||||||||
– Default |
– |
– |
– |
– |
– | – | – | – | ||||||||||||||||||||||||
– Not rated |
– |
– | ||||||||||||||||||||||||||||||
Gross credit card |
– |
– | ||||||||||||||||||||||||||||||
ECL allowance |
– |
– | ||||||||||||||||||||||||||||||
Net credit card |
– |
– | ||||||||||||||||||||||||||||||
Business and government |
||||||||||||||||||||||||||||||||
– Investment grade |
– |
– | ||||||||||||||||||||||||||||||
– Non-investment grade |
– |
– | ||||||||||||||||||||||||||||||
– Watch list |
– |
– | ||||||||||||||||||||||||||||||
– Default |
– |
– |
– | – | ||||||||||||||||||||||||||||
– Not rated |
– |
– | ||||||||||||||||||||||||||||||
Gross business and government (4)(6) |
||||||||||||||||||||||||||||||||
ECL allowance |
||||||||||||||||||||||||||||||||
Net business and government |
||||||||||||||||||||||||||||||||
Total net amount of loans |
$ |
$ |
$ |
$ |
$ | $ | $ | |
$ |
(1) | The table excludes debt securities measured at FVOCI, for which ECL allowances of $ 4 (2023: $4 and October 31, 2023 . Financial assets other than loans that are classified as amortized cost are presented on our consolidated balance sheet net of ECL allowances. |
(2) | Excludes foreclosed assets of $ |
(3) | As at October 31, 202 4 , |
(4) | Includes $ |
(5) | The internal risk rating grades presented for residential mortgages and certain personal loans do not take into account loan guarantees or insurance issued by the Canadian government (federal or provincial), Canadian government agencies, or private insurers, as the determination of whether a SICR has occurred for these loans is based on relative changes in the loans’ lifetime PD without considering collateral or other credit enhancements. |
(6) | Includes customers’ liability under acceptances of $ |
CIBC 2024 |
|
14 3 |
Consolidated financial statements |
$ millions, as at October 31 |
2024 |
2023 | ||||||||||||||||||||||||||||||
Stage 1 |
Stage 2 |
Stage 3 |
Total |
Stage 1 | Stage 2 | Stage 3 | Total | |||||||||||||||||||||||||
Retail |
||||||||||||||||||||||||||||||||
– Exceptionally low |
$ |
$ |
$ |
– |
$ |
$ | $ | $ | – | $ | ||||||||||||||||||||||
– Very low |
– |
– | ||||||||||||||||||||||||||||||
– Low |
– |
– | ||||||||||||||||||||||||||||||
– Medium |
– |
– | ||||||||||||||||||||||||||||||
– High |
– |
– | ||||||||||||||||||||||||||||||
– Default |
– |
– |
– | – | ||||||||||||||||||||||||||||
– Not rated |
– |
– | ||||||||||||||||||||||||||||||
Gross retail |
||||||||||||||||||||||||||||||||
ECL allowance |
– |
– | ||||||||||||||||||||||||||||||
Net retail |
||||||||||||||||||||||||||||||||
Business and government |
||||||||||||||||||||||||||||||||
– Investment grade |
– |
– | ||||||||||||||||||||||||||||||
– Non-investment grade |
– |
– | ||||||||||||||||||||||||||||||
– Watch list |
– |
– | ||||||||||||||||||||||||||||||
– Default |
– |
– |
– | – | ||||||||||||||||||||||||||||
– Not rated |
– |
– | ||||||||||||||||||||||||||||||
Gross business and government |
||||||||||||||||||||||||||||||||
ECL allowance |
– | |||||||||||||||||||||||||||||||
Net business and government |
||||||||||||||||||||||||||||||||
Total net undrawn credit facilities and other off-balance sheet exposures |
$ |
$ |
$ |
$ |
$ | |
$ | |
$ | |
$ | |
$ millions, for the year ended October 31 |
2024 |
2023 |
||||||
Interest income |
$ |
$ | |
|||||
Interest expense |
||||||||
Net interest income |
||||||||
Provision for credit losses |
||||||||
Net interest income after provision for credit losses |
$ |
$ |
Note 6 |
Structured entities and derecognition of financial assets |
14 4 |
CIBC 2024 |
Consolidated financial statements |
CIBC 2024 |
|
14 5 |
Consolidated financial statements |
$ millions, as at October 31, 2024 |
Single-seller and multi-seller conduits |
Third-party structured vehicles |
Loan financing |
Other (1) |
||||||||||||
On-balance sheet assets at carrying value (2) |
||||||||||||||||
Cash and non-interest-bearing deposits with banks |
$ |
– |
$ |
– |
$ |
– |
$ |
|||||||||
Securities |
– |
|||||||||||||||
Loans |
||||||||||||||||
Investments in equity-accounted associates and joint ventures |
– |
– |
||||||||||||||
$ |
$ |
$ |
$ |
|||||||||||||
October 31, 2023 |
$ | $ | $ | $ | |
|||||||||||
On-balance sheet liabilities at carrying value (2) |
||||||||||||||||
Deposits |
$ |
– |
$ |
– |
$ |
– |
$ |
|||||||||
Derivatives (3) |
– |
– |
– |
|||||||||||||
Other |
– |
– |
– |
|||||||||||||
$ |
– |
$ |
– |
$ |
– |
$ |
||||||||||
October 31, 2023 |
$ | – | $ | – | $ | – | $ | |||||||||
Maximum exposure to loss, net of hedges |
||||||||||||||||
Investments and loans |
$ |
$ |
$ |
$ |
||||||||||||
Notional of written derivatives, less fair value losses |
– |
– |
– |
|||||||||||||
Liquidity, credit facilities and commitments |
(4) |
|||||||||||||||
Less: hedges of investments, loans and written derivatives exposure |
– |
– |
– |
( |
) | |||||||||||
$ |
$ |
$ |
$ |
|||||||||||||
October 31, 2023 |
$ | |
$ | |
$ | |
$ |
(1) | Includes Community Reinvestment Act |
(2) | Excludes SEs established by CMHC, Fannie Mae, Freddie Mac, Ginnie Mae, FHLB, Federal Farm Credit Bank, and Student Loan Marketing Association. |
(3) | Comprises written credit default swaps (CDS) and total return swaps (TRS) under which we assume exposures. Excludes foreign exchange derivatives, interest rate derivatives and other derivatives provided as part of normal client facilitation. |
(4) | Excludes an additional $ |
1 46 |
CIBC 2024 |
Consolidated financial statements |
$ millions, as at October 31 |
2024 |
2023 |
||||||||||||||
Carrying amount |
Fair value |
Carrying amount |
Fair value |
|||||||||||||
Residential mortgage securitizations (1) |
$ |
$ |
$ |
$ |
||||||||||||
Securities held by counterparties as collateral under repurchase agreements (2) |
||||||||||||||||
Securities lent for cash collateral (2) |
||||||||||||||||
Securities lent for securities collateral (2) |
||||||||||||||||
$ |
$ |
$ |
$ |
|||||||||||||
Associated liabilities (3) |
$ |
$ |
$ |
$ |
(1) | Consists mainly of Canadian residential mortgage loans transferred to Canada Housing Trust. Certain cash in transit balances related to the securitization process amounting to $ |
(2) | Does not include over-collateralization of assets pledged. Repurchase and securities lending arrangements are conducted with both CIBC-owned and third-party assets on a pooled basis. The carrying amounts represent an estimated allocation related to the transfer of our own financial assets. |
(3) | Includes the obligation to return off-balance sheet securities collateral on securities lent and fair value hedge basis adjustments. |
CIBC 2024 |
|
1 47 |
Consolidated financial statements |
Note 7 |
Property and equipment |
$ millions, as at or for the year ended October 31 |
Right-of- use assets |
Land and buildings (1) |
Computer equipment |
Office furniture, equipment and other (1) |
Leasehold improvements (1) |
Total | ||||||||||||||||||||
2024 |
Cost |
|||||||||||||||||||||||||
Balance at beginning of year |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||||
Additions (2) |
||||||||||||||||||||||||||
Disposals (3) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||||
Adjustments (4) |
||||||||||||||||||||||||||
Balance at end of year |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||||
2023 |
Balance at end of year |
$ | $ | $ | |
$ | |
$ | |
$ | |
|||||||||||||||
2024 |
Accumulated depreciation |
|||||||||||||||||||||||||
Balance at beginning of year |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||||
Depreciation |
||||||||||||||||||||||||||
Disposals (3) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||||
Adjustments (4) |
– |
– |
||||||||||||||||||||||||
Balance at end of year |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||||
2023 |
Balance at end of year |
$ | $ | $ | $ | $ | $ | |||||||||||||||||||
Net book value |
||||||||||||||||||||||||||
As at October 31, 2024 |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||||
As at October 31, 2023 |
$ | |
$ | |
$ | $ | $ | $ |
(1) | Includes $ |
(2) | Includes impact of lease modifications. |
(3) | Includes write-offs of fully depreciated assets. |
(4) | Includes foreign currency translation adjustments. |
Note 8 |
Goodwill, software and other intangible assets |
CGUs |
||||||||||||||||||
$ millions, as at or for the year ended October 31 |
Canadian Wealth Management |
U.S. Commercial Banking and Wealth Management |
Other |
Total |
||||||||||||||
2024 |
Balance at beginning of year |
$ |
$ |
$ |
$ |
|||||||||||||
Impairment |
– |
– |
– |
– |
||||||||||||||
Adjustments (1) |
– |
– |
||||||||||||||||
Balance at end of year |
$ |
$ |
$ |
$ |
||||||||||||||
2023 |
Balance at beginning of year | $ | $ | $ | $ | |||||||||||||
Impairment |
– | – | – | – | ||||||||||||||
Adjustments (1) |
– | |||||||||||||||||
Balance at end of year | $ | |
$ | |
$ | |
$ | |
(1) | Includes foreign currency translation adjustments. |
1 48 |
CIBC 2024 |
Consolidated financial statements |
$ millions, as at or for the year ended October 31 |
Contract based (1) |
Brand name (2) |
Total | |||||||||||
2024 |
Balance at beginning of year |
$ |
$ |
– |
$ |
|||||||||
Impairment |
– |
– |
– |
|||||||||||
Balance at end of year |
$ |
$ |
– |
$ |
||||||||||
2023 |
Balance at beginning of year | $ | $ | |
$ | |||||||||
Impairment | – | ( |
) | ( |
) | |||||||||
Balance at end of year | $ | |
$ | – | $ | |
(1) | Represents management contracts purchased as part of past acquisitions. |
(2) | Acquired as part of the CIBC Caribbean acquisition. On October 31, 2023, CIBC Caribbean announced its intent to rebrand as CIBC, and we therefore recognized an impairment charge of $ |
CIBC 2024 |
|
1 49 |
Consolidated financial statements |
$ millions, as at or for the year ended October 31 |
Software (1) |
Core deposit intangibles (2) |
Contract based |
Customer relationships (3) |
Total |
|||||||||||||||||
2024 |
Gross carrying amount |
|||||||||||||||||||||
Balance at beginning of year |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||
Additions |
– |
– |
– |
|||||||||||||||||||
Disposals (4) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||
Adjustments (5) |
– |
– |
||||||||||||||||||||
Balance at end of year |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||
2023 |
Balance at end of year |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||
2024 |
Accumulated amortization |
|||||||||||||||||||||
Balance at beginning of year |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||
Amortization and impairment (4) |
||||||||||||||||||||||
Disposals (4) |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||
Adjustments (5) |
– |
– |
||||||||||||||||||||
Balance at end of year |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||
2023 |
Balance at end of year |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||
Net book value |
||||||||||||||||||||||
As at October 31, 2024 |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||
As at October 31, 2023 |
$ |
$ |
$ |
$ |
$ |
(1) | Includes $ |
(2) | Acquired as part of the acquisition of The PrivateBank. |
(3) | Represents customer relationships associated with past acquisitions including of the Canadian Costco credit card portfolio in 2022. |
(4) | Includes write-offs of fully amortized assets. |
(5) | Includes foreign currency translation. |
Note 9 |
Other assets |
$ millions, as at October 31 |
2024 |
2023 |
||||||
Accrued interest receivable |
$ |
$ | ||||||
Defined benefit asset (Note 17) |
||||||||
Precious metals (1) |
||||||||
Brokers’ client accounts |
||||||||
Current tax receivable |
||||||||
Other prepayments |
||||||||
Derivative collateral receivable |
||||||||
Accounts receivable |
||||||||
Other (2)(3) |
||||||||
$ |
$ | |
(1) | Includes gold and silver bullion that are measured at fair value using unadjusted market prices quoted in active markets. |
(2) | Includes investments in subleases of $ million). For the year ended October 31, 2024, finance income related to our investments in subleases was $ 3 : $ |
(3) | Certain prior year information has been restated to reflect the adoption of IFRS 17. See Note 1 to the consolidated financial statements for additional details. |
15 0 |
CIBC 2024 |
Consolidated financial statements |
Note 10 |
Deposits (1)(2) |
$ millions, as at October 31 |
Payable on demand (3) |
Payable after notice (4) |
Payable on a fixed date (5)(6) |
2024 Total |
2023 Total |
|||||||||||||||
Personal |
$ |
$ |
$ |
$ |
$ | |||||||||||||||
Business and government (7) |
||||||||||||||||||||
Bank |
||||||||||||||||||||
Secured borrowings (8) |
– |
– |
||||||||||||||||||
$ |
$ |
$ |
$ |
$ | ||||||||||||||||
Comprises: |
||||||||||||||||||||
Held at amortized cost |
$ |
$ | ||||||||||||||||||
Designated at fair value |
||||||||||||||||||||
$ |
$ | |||||||||||||||||||
Total deposits include: (9) |
||||||||||||||||||||
Non-interest-bearing deposits |
||||||||||||||||||||
Canada |
$ |
$ | ||||||||||||||||||
U.S. |
||||||||||||||||||||
Other international |
||||||||||||||||||||
Interest-bearing deposits |
||||||||||||||||||||
Canada |
||||||||||||||||||||
U.S. |
||||||||||||||||||||
Other international |
||||||||||||||||||||
$ |
$ | |
(1) | Includes deposits of $ |
(2) | Net of purchased notes of $ |
(3) | Includes all deposits for which we do not have the right to require notice of withdrawal. These deposits are generally chequing accounts. |
(4) | Includes all deposits for which we can legally require notice of withdrawal. These deposits are generally savings accounts. |
(5) | Includes all deposits that mature on a specified date. These deposits are generally term deposits, guaranteed investment certificates, and similar instruments. |
(6) | Includes $ |
(7) | Includes $ |
(8) | Comprises liabilities issued by or as a result of activities associated with the securitization of residential mortgages, Covered Bond Programme, and consolidated securitization vehicles. |
(9) | Classification is based on geographical location of the CIBC office. |
Note 11 |
Other liabilities |
$ millions, as at October 31 |
2024 |
2023 |
||||||
Accrued interest payable |
$ |
$ | ||||||
Defined benefit liability (Note 1 7 ) |
||||||||
Gold and silver certificates |
||||||||
Brokers’ client accounts |
||||||||
Derivative collateral payable |
||||||||
Negotiable instruments |
||||||||
Accrued employee compensation and benefits |
||||||||
Accounts payable and accrued expenses |
||||||||
Other (1)(2) |
||||||||
$ |
$ | |
(1) | Includes the carrying value of our lease liabilities, which was $ $ million between years 1-5, and $ |
( 2 ) |
Certain prior year information has been restated to reflect the adoption of IFRS 17. See Note 1 to the consolidated financial statements for additional details. |
Note 12 |
Derivative instruments |
$ millions, as at October 31 |
2024 |
2023 |
||||||||||||||
Assets |
Liabilities |
Assets |
Liabilities |
|||||||||||||
Trading (Note 2) |
$ |
$ |
$ |
$ |
||||||||||||
ALM (Note 2) (1) |
||||||||||||||||
$ |
$ |
$ |
$ |
(1) | Comprised of derivatives that qualify for hedge accounting under IAS 39 and derivatives used for economic hedges. |
CIBC 2024 |
|
15 1 |
Consolidated financial statements |
15 2 |
CIBC 2024 |
Consolidated financial statements |
$ millions, as at October 31 | 2024 |
2023 | ||||||||||||||||||||||||||||||
Residual term to contractual maturity |
||||||||||||||||||||||||||||||||
Less than 1 year |
1 to 5 years |
Over 5 years |
Total notional amounts |
Trading |
ALM |
Trading | ALM | |||||||||||||||||||||||||
Interest rate derivatives |
||||||||||||||||||||||||||||||||
Over-the-counter |
||||||||||||||||||||||||||||||||
Forward rate agreements |
$ |
$ |
$ |
– |
$ |
$ |
$ |
$ | $ | |||||||||||||||||||||||
Centrally cleared forward rate agreements |
– |
– |
– | |||||||||||||||||||||||||||||
Swap contracts |
||||||||||||||||||||||||||||||||
Centrally cleared swap contracts |
|
|
||||||||||||||||||||||||||||||
Purchased options |
||||||||||||||||||||||||||||||||
Written options |
||||||||||||||||||||||||||||||||
Exchange-traded |
||||||||||||||||||||||||||||||||
Futures contracts |
– |
|||||||||||||||||||||||||||||||
Purchased options |
– |
– |
– |
– | ||||||||||||||||||||||||||||
Written options |
– |
– |
– |
– | ||||||||||||||||||||||||||||
– |
||||||||||||||||||||||||||||||||
Total interest rate derivatives |
||||||||||||||||||||||||||||||||
Foreign exchange derivatives |
||||||||||||||||||||||||||||||||
Over-the-counter |
||||||||||||||||||||||||||||||||
Forward contracts |
||||||||||||||||||||||||||||||||
Swap contracts |
||||||||||||||||||||||||||||||||
Purchased options |
– |
|||||||||||||||||||||||||||||||
Written options |
– |
|||||||||||||||||||||||||||||||
Exchange-traded |
||||||||||||||||||||||||||||||||
Futures contracts |
– |
– |
– |
– | ||||||||||||||||||||||||||||
Purchased options |
– |
– |
– |
– | ||||||||||||||||||||||||||||
Written options |
– |
– |
– |
– | ||||||||||||||||||||||||||||
– |
– |
– |
– | |||||||||||||||||||||||||||||
Total foreign exchange derivatives |
||||||||||||||||||||||||||||||||
Credit derivatives |
||||||||||||||||||||||||||||||||
Over-the-counter |
||||||||||||||||||||||||||||||||
Credit default swap contracts – protection purchased |
||||||||||||||||||||||||||||||||
Centrally cleared credit default swap contracts – protection purchased |
– |
– | ||||||||||||||||||||||||||||||
Credit default swap contracts – protection sold |
– |
– | ||||||||||||||||||||||||||||||
Centrally cleared credit default swap contracts – protection sold |
– |
– | ||||||||||||||||||||||||||||||
Total credit derivatives |
||||||||||||||||||||||||||||||||
Equity derivatives |
||||||||||||||||||||||||||||||||
Over-the-counter |
||||||||||||||||||||||||||||||||
Exchange-traded |
– |
– | ||||||||||||||||||||||||||||||
Total equity derivatives |
||||||||||||||||||||||||||||||||
Precious metal and other commodity derivatives |
||||||||||||||||||||||||||||||||
Over-the-counter |
||||||||||||||||||||||||||||||||
Centrally cleared commodity derivatives |
– |
– |
– | |||||||||||||||||||||||||||||
Exchange-traded |
– |
– | ||||||||||||||||||||||||||||||
Total precious metal and other commodity derivatives |
||||||||||||||||||||||||||||||||
Total notional amount of which: |
$ |
$ |
$ |
$ |
$ |
$ |
$ | |
$ | |
||||||||||||||||||||||
Over-the-counter (1) |
||||||||||||||||||||||||||||||||
Exchange-traded |
(1) | For OTC derivatives that are not centrally cleared, $ 3 : $3 : $ |
CIBC 2024 |
|
15 3 |
Consolidated financial statements |
$ millions, as at October 31 |
2024 |
2023 | ||||||||||||||||||||||||||||||||||||||
Current replacement cost (1) |
Credit equivalent amount (2) |
Risk- weighted amount |
Current replacement cost (1) |
Credit equivalent amount (2) |
Risk- weighted amount |
|||||||||||||||||||||||||||||||||||
Trading |
ALM |
Total |
Trading | ALM | Total | |||||||||||||||||||||||||||||||||||
Interest rate derivatives |
||||||||||||||||||||||||||||||||||||||||
Over-the-counter |
||||||||||||||||||||||||||||||||||||||||
Forward rate agreements |
$ |
$ |
$ |
$ |
$ |
$ | $ | – | $ | $ | $ | |||||||||||||||||||||||||||||
Swap contracts |
||||||||||||||||||||||||||||||||||||||||
Purchased options |
– | |||||||||||||||||||||||||||||||||||||||
Written options |
– | |||||||||||||||||||||||||||||||||||||||
Exchange-traded |
– |
– | ||||||||||||||||||||||||||||||||||||||
Foreign exchange derivatives |
||||||||||||||||||||||||||||||||||||||||
Over-the-counter |
||||||||||||||||||||||||||||||||||||||||
Forward contracts |
||||||||||||||||||||||||||||||||||||||||
Swap contracts |
||||||||||||||||||||||||||||||||||||||||
Purchased options |
– |
– | ||||||||||||||||||||||||||||||||||||||
Written options |
– |
– | ||||||||||||||||||||||||||||||||||||||
Exchange-traded |
– |
– |
– |
– | – | – | ||||||||||||||||||||||||||||||||||
Credit derivatives |
||||||||||||||||||||||||||||||||||||||||
Over-the-counter |
||||||||||||||||||||||||||||||||||||||||
Credit default swap contracts |
||||||||||||||||||||||||||||||||||||||||
– protection purchased |
– |
|||||||||||||||||||||||||||||||||||||||
– protection sold |
– |
– |
– |
– | ||||||||||||||||||||||||||||||||||||
– |
||||||||||||||||||||||||||||||||||||||||
Equity derivatives |
||||||||||||||||||||||||||||||||||||||||
Over-the-counter |
||||||||||||||||||||||||||||||||||||||||
Exchange-traded |
– |
– | ||||||||||||||||||||||||||||||||||||||
Precious metal and other commodity derivatives |
||||||||||||||||||||||||||||||||||||||||
Over-the-counter |
– | |||||||||||||||||||||||||||||||||||||||
Exchange-traded |
– |
– | ||||||||||||||||||||||||||||||||||||||
– | ||||||||||||||||||||||||||||||||||||||||
RWA related to non-trade exposures to central counterparties |
||||||||||||||||||||||||||||||||||||||||
RWA related to CVA capital charge (3) |
||||||||||||||||||||||||||||||||||||||||
Total derivatives |
$ |
$ |
$ |
$ |
$ |
$ | |
$ | |
$ | |
$ | |
$ | |
(1) | Current replacement cost reflects the current mark-to-market (MTM) value of derivatives offset by eligible financial collateral, where present. |
(2) | Under IMM, expected effective positive exposure (EEPE) is used, which computes, through simulation, the expected exposures with consideration to the expected movements in underlying risk factor and netting/collateral agreements. The EAD is calculated as EEPE multiplied by the prescribed alpha factor of 1.4. The EAD under SA-CCR is calculated as the sum of replacement cost and potential future exposure, multiplied by the prescribed alpha factor of 1.4. |
(3) |
2024 reflects the implementation of Basel III reforms related to market risk and CVA. |
154 |
CIBC 2024 |
Consolidated financial statements |
$ millions, as at October 31 |
2024 |
2023 |
||||||||||||||||||||||||||||||
Canada |
U.S. |
Other countries |
Total |
Canada |
U.S. |
Other countries |
Total |
|||||||||||||||||||||||||
Derivative instruments |
||||||||||||||||||||||||||||||||
By counterparty type |
||||||||||||||||||||||||||||||||
Financial institutions |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||||||||
Governments |
– |
– |
||||||||||||||||||||||||||||||
Corporate |
||||||||||||||||||||||||||||||||
Total derivative instruments |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
Note 13 |
Designated accounting hedges |
• | Utilization of hedging instruments that have a non-zero fair value at the inception of the hedge relationship; |
• | Differences in fixed rates, when contractual coupons of the fixed rate hedged items are designated; |
• | Differences in the discounting factors between the hedged item and the hedging instruments arising from different rate reset frequencies and timing of cash flows; and |
• | Differences in the discount curves to determine the basis adjustments of the hedged items and the fair value of the hedging derivatives, including from the application of CVA to the valuation of derivatives when they are applicable. |
CIBC 2024 |
|
155 |
Consolidated financial statements |
Notional amount of the hedging instrument (1) |
Maturity range | Fair value of the hedging derivatives |
Gains (losses) on changes in fair value used for calculating hedge ineffectiveness |
|||||||||||||||||||||||||||
$ millions, as at October 31 |
Less than 1 year |
1-5 years |
Over 5 years |
Assets | Liabilities | |||||||||||||||||||||||||
2024 |
Cash flow hedges |
|||||||||||||||||||||||||||||
Foreign exchange risk |
||||||||||||||||||||||||||||||
Cross-currency interest rate swaps |
$ |
$ |
$ |
$ |
– |
$ |
$ |
$ |
||||||||||||||||||||||
Interest rate risk |
||||||||||||||||||||||||||||||
Interest rate swaps |
– |
|||||||||||||||||||||||||||||
Equity share price risk |
||||||||||||||||||||||||||||||
Equity swaps |
– |
|||||||||||||||||||||||||||||
$ |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||||||||
NIFO hedges |
||||||||||||||||||||||||||||||
Foreign exchange risk |
||||||||||||||||||||||||||||||
Foreign exchange forwards |
$ |
$ |
$ |
– |
$ |
– |
$ |
$ |
$ |
( |
) | |||||||||||||||||||
Deposits (2) |
– |
– |
n/a |
n/a |
( |
) | ||||||||||||||||||||||||
$ |
$ |
$ |
– |
$ |
– |
$ |
$ |
$ |
( |
) | ||||||||||||||||||||
Fair value hedges |
||||||||||||||||||||||||||||||
Interest rate risk |
||||||||||||||||||||||||||||||
Interest rate swaps |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
( |
) | |||||||||||||||||||||
Foreign exchange / interest rate risk |
||||||||||||||||||||||||||||||
Cross-currency interest rate swaps |
||||||||||||||||||||||||||||||
Interest rate swaps |
– |
|||||||||||||||||||||||||||||
$ |
$ |
$ |
$ |
$ |
$ |
$ |
( |
) | ||||||||||||||||||||||
$ |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||||||||
2023 |
Cash flow hedges |
|||||||||||||||||||||||||||||
Foreign exchange risk |
||||||||||||||||||||||||||||||
Cross-currency interest rate swaps |
$ | $ | $ | $ | – | $ | $ | $ | ||||||||||||||||||||||
Interest rate risk |
||||||||||||||||||||||||||||||
Interest rate swaps |
– | ( |
) | |||||||||||||||||||||||||||
Equity share price risk |
||||||||||||||||||||||||||||||
Equity swaps |
– | ( |
) | |||||||||||||||||||||||||||
$ | $ | $ | $ | $ | $ | $ | ( |
) | ||||||||||||||||||||||
NIFO hedges |
||||||||||||||||||||||||||||||
Foreign exchange risk |
||||||||||||||||||||||||||||||
Foreign exchange forwards |
$ | $ | $ | – | $ | – | $ | $ | $ | ( |
) | |||||||||||||||||||
Deposits (2) |
– | – | n/a | n/a | ( |
) | ||||||||||||||||||||||||
$ | $ | $ | – | $ | – | $ | $ | $ | ( |
) | ||||||||||||||||||||
Fair value hedges |
||||||||||||||||||||||||||||||
Interest rate risk |
||||||||||||||||||||||||||||||
Interest rate swaps |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||
Foreign exchange / interest rate risk |
||||||||||||||||||||||||||||||
Cross-currency interest rate swaps |
( |
) | ||||||||||||||||||||||||||||
Interest rate swaps |
– | |||||||||||||||||||||||||||||
$ | $ | $ | $ | $ | $ | |
$ | |
||||||||||||||||||||||
$ | |
$ | |
$ | |
$ | |
$ | |
$ | $ |
(1) | For some hedge relationships, we apply a combination of derivatives to hedge the underlying exposures; therefore, the notional amounts of the derivatives generally exceed the carrying amount of the hedged items. |
(2) | Notional amount represents the principal amount of deposits as at October 31, 2024 and October 31, 2023. |
n/a | Not applicable. |
156 |
CIBC 2024 |
Consolidated financial statements |
As at October 31 |
Average exchange rate (1) |
Average fixed interest rate (1) |
Average share price |
|||||||||||||||||
2024 |
Cash flow hedges |
|||||||||||||||||||
Foreign exchange risk |
||||||||||||||||||||
Cross-currency interest rate swaps |
AUD – CAD | n/a |
n/a |
|||||||||||||||||
EUR – CAD | n/a |
n/a |
||||||||||||||||||
GBP – CAD | n/a |
n/a |
||||||||||||||||||
Interest rate risk |
||||||||||||||||||||
Interest rate swaps |
n/a |
CAD | % |
n/a |
||||||||||||||||
n/a |
USD | % |
n/a |
|||||||||||||||||
Equity share price risk |
||||||||||||||||||||
Equity swaps |
n/a |
n/a |
$ |
|||||||||||||||||
NIFO hedges |
||||||||||||||||||||
Foreign exchange risk |
||||||||||||||||||||
Foreign exchange forwards |
AUD – CAD | n/a |
n/a |
|||||||||||||||||
HKD – CAD | n/a |
n/a |
||||||||||||||||||
Fair value hedges |
||||||||||||||||||||
Interest rate risk |
||||||||||||||||||||
Interest rate swaps |
n/a |
CAD | % |
n/a |
||||||||||||||||
Foreign exchange / interest rate risk |
||||||||||||||||||||
Cross-currency interest rate swaps |
EUR – CAD | % |
n/a |
|||||||||||||||||
CHF – CAD | n/a |
n/a |
||||||||||||||||||
USD – CAD | % |
n/a |
||||||||||||||||||
Interest rate swaps |
n/a |
CHF | % |
n/a |
||||||||||||||||
n/a |
EUR |
% |
n/a |
|||||||||||||||||
n/a |
GBP | % |
n/a |
|||||||||||||||||
2023 |
Cash flow hedges |
|||||||||||||||||||
Foreign exchange risk |
||||||||||||||||||||
Cross-currency interest rate swaps |
AUD – CAD | n/a | n/a | |||||||||||||||||
EUR – CAD | n/a | n/a | ||||||||||||||||||
GBP – CAD | n/a | n/a | ||||||||||||||||||
Interest rate risk |
||||||||||||||||||||
Interest rate swaps |
n/a | CAD | % |
n/a | ||||||||||||||||
n/a | USD | % |
n/a | |||||||||||||||||
Equity share price risk |
||||||||||||||||||||
Equity swaps |
n/a | n/a | $ | |
||||||||||||||||
NIFO hedges |
||||||||||||||||||||
Foreign exchange risk |
||||||||||||||||||||
Foreign exchange forwards |
AUD – CAD | n/a | n/a | |||||||||||||||||
HKD – CAD | n/a | n/a | ||||||||||||||||||
Fair value hedges |
||||||||||||||||||||
Interest rate risk |
||||||||||||||||||||
Interest rate swaps |
n/a | CAD | % | n/a | ||||||||||||||||
Foreign exchange / interest rate risk |
||||||||||||||||||||
Cross-currency interest rate swaps |
EUR – CAD | % | n/a | |||||||||||||||||
CHF – CAD | n/a | n/a | ||||||||||||||||||
USD – CAD | % | n/a | ||||||||||||||||||
Interest rate swaps |
n/a | CHF | % | n/a | ||||||||||||||||
n/a | EUR | % | n/a | |||||||||||||||||
n/a | GBP | % | n/a |
(1) | Includes average foreign exchange rates and interest rates relating to significant hedging relationships. |
n/a | Not applicable. |
CIBC 2024 |
|
157 |
Consolidated financial statements |
Carrying amount of the hedged item |
Accumulated amount of fair value hedge adjustments on the hedged item |
Gains (losses) on change in fair value used for calculating hedge ineffectiveness |
||||||||||||||||||||
$ millions, as at or for the year ended October 31 |
Assets |
Liabilities |
Assets |
Liabilities |
||||||||||||||||||
2024 |
Cash flow hedges (1) |
|||||||||||||||||||||
Foreign exchange risk |
||||||||||||||||||||||
Deposits |
$ |
– |
$ |
n/a |
n/a |
$ |
( |
) | ||||||||||||||
Interest rate risk |
||||||||||||||||||||||
Loans |
– |
n/a |
n/a |
( |
) | |||||||||||||||||
Equity share price risk |
||||||||||||||||||||||
Share-based payment |
– |
n/a |
n/a |
( |
) | |||||||||||||||||
$ |
$ |
n/a |
n/a |
$ |
( |
) | ||||||||||||||||
NIFO hedges |
$ |
$ |
– |
n/a |
n/a |
$ |
||||||||||||||||
Fair value hedges (2) |
||||||||||||||||||||||
Interest rate risk |
||||||||||||||||||||||
Securities |
$ |
$ |
– |
$ |
( |
) |
$ |
– |
$ |
|||||||||||||
Loans |
– |
– |
||||||||||||||||||||
Deposits |
– |
– |
( |
) |
( |
) | ||||||||||||||||
Subordinated indebtedness |
– |
– |
( |
) | ||||||||||||||||||
Foreign exchange / interest rate risk |
||||||||||||||||||||||
Deposits |
– |
– |
( |
) |
( |
) | ||||||||||||||||
$ |
$ |
$ |
$ |
( |
) |
$ |
||||||||||||||||
2023 |
Cash flow hedges (1) |
|||||||||||||||||||||
Foreign exchange risk |
||||||||||||||||||||||
Deposits |
$ | – | $ | n/a | n/a | $ | ( |
) | ||||||||||||||
Interest rate risk |
||||||||||||||||||||||
Loans |
– | n/a | n/a | |||||||||||||||||||
Equity share price risk |
||||||||||||||||||||||
Share-based payment |
– | n/a | n/a | |||||||||||||||||||
$ | $ | n/a | n/a | $ | ||||||||||||||||||
NIFO hedges |
$ | $ | – | n/a | n/a | $ | ||||||||||||||||
Fair value hedges (2) |
||||||||||||||||||||||
Interest rate risk |
||||||||||||||||||||||
Securities |
$ | $ | – | $ | ( |
) | $ | – | $ | ( |
) | |||||||||||
Loans |
– | ( |
) | – | ( |
) | ||||||||||||||||
Deposits |
– | – | ( |
) | ||||||||||||||||||
Subordinated indebtedness |
– | – | ( |
) | ||||||||||||||||||
Foreign exchange / interest rate risk |
||||||||||||||||||||||
Deposits |
– | – | ( |
) | ( |
) | ||||||||||||||||
$ | |
$ | |
$ | ( |
) | $ | ( |
) | $ | ( |
) |
(1) | As at October 31, 2024, the amount remaining in AOCI related to discontinued cash flow hedges was a net loss of $ |
(2) | As at October 31, 2024, the accumulated fair value hedge net liability adjustment remaining on the consolidated balance sheet related to discontinued fair value hedges was $ |
n/a | Not applicable. |
$ millions, for the year ended October 31 |
Beginning balance of AOCI – hedge reserve (after-tax) |
Change in the value of the hedging instrument recognized in OCI (before-tax) |
Amount reclassified from accumulated OCI to income (before-tax) (1) |
Tax benefit (expense) |
Ending balance of AOCI hedge reserve (after-tax) |
Hedge ineffectiveness gains (losses) recognized in income |
||||||||||||||||||||
2024 |
Cash flow hedges |
|||||||||||||||||||||||||
Foreign exchange risk |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
||||||||||||
Interest rate risk |
( |
) |
( |
) |
||||||||||||||||||||||
Equity share price risk |
( |
) |
( |
) |
( |
) |
– |
|||||||||||||||||||
$ |
( |
) |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
|||||||||||||||
NIFO hedges – foreign exchange risk |
||||||||||||||||||||||||||
Hedges of net investment in foreign operations |
$ |
( |
) |
$ |
( |
) |
$ |
– |
$ |
– |
$ |
( |
) |
$ |
– |
|||||||||||
2023 |
Cash flow hedges |
|||||||||||||||||||||||||
Foreign exchange risk |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
– |
|||||||||||||
Interest rate risk |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||
Equity share price risk |
( |
) |
( |
) |
– |
|||||||||||||||||||||
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
|||||||||||||
NIFO hedges – foreign exchange risk |
||||||||||||||||||||||||||
Hedges of net investment in foreign operations |
$ |
( |
) |
$ |
( |
) |
$ |
– |
$ |
$ |
( |
) |
$ |
– |
(1) | During the year ended October 31, 2024, the amount reclassified from AOCI to net income for cash flow hedges of forecasted transactions that were no longer expected to occur was |
158 |
CIBC 2024 |
Consolidated financial statements |
$ millions, for the year ended October 31 |
Gains (losses) on the hedging instruments |
Gains (losses) on the hedged items attributable to hedged risk |
Hedge ineffectiveness gains (losses) recognized in income |
|||||||||||
2024 |
Fair value hedges |
|||||||||||||
Interest rate risk |
$ |
( |
) |
$ |
$ |
|||||||||
Foreign exchange / interest rate risk |
( |
) |
||||||||||||
$ |
( |
) |
$ |
$ |
||||||||||
2023 |
Fair value hedges |
|||||||||||||
Interest rate risk |
$ | $ | ( |
) | $ | ( |
) | |||||||
Foreign exchange / interest rate risk |
( |
) | ( |
) | ||||||||||
$ | $ | ( |
) | $ | ( |
) |
Note 14 |
Subordinated indebtedness |
$ millions, as at October 31 |
2024 |
2023 |
||||||||||||||||||||||||||||||||
Earliest date redeemable |
||||||||||||||||||||||||||||||||||
Interest rate % |
Contractual maturity date |
At greater of Canada Yield Price (1) and par |
At par |
Denominated in foreign currency |
Par value |
Carrying value (2) |
Par value |
Carrying value (2) |
||||||||||||||||||||||||||
(3) |
(4) |
TT$ |
$ |
– |
$ |
– |
$ | $ | ||||||||||||||||||||||||||
(4) |
||||||||||||||||||||||||||||||||||
(5)(6) |
– |
– |
||||||||||||||||||||||||||||||||
(5)(7) |
||||||||||||||||||||||||||||||||||
(5)(8) |
||||||||||||||||||||||||||||||||||
(5)(9) |
||||||||||||||||||||||||||||||||||
(4) |
||||||||||||||||||||||||||||||||||
(5)(10) |
||||||||||||||||||||||||||||||||||
(5)(11) |
||||||||||||||||||||||||||||||||||
(4) |
||||||||||||||||||||||||||||||||||
(5)(12) |
– | – | ||||||||||||||||||||||||||||||||
(5)(13) |
– | – | ||||||||||||||||||||||||||||||||
(4) |
||||||||||||||||||||||||||||||||||
(14) |
US$ |
|||||||||||||||||||||||||||||||||
(15) |
US$ |
|||||||||||||||||||||||||||||||||
Subordinated indebtedness sold short (held) for trading purposes |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
$ |
$ |
$ | |
$ | |
(1) | Canada Yield Price: a price calculated at the time of redemption to provide a yield to maturity equal to the yield of a Government of Canada bond of appropriate maturity plus a pre-determined spread. |
(2) | Carrying values of fixed-rate subordinated indebtedness notes reflect the impact of interest rate hedges in an effective hedge relationship. |
(3) | On July 11, 2024, we redeemed all $ |
(4) | Not redeemable prior to maturity date. |
(5) | Debentures are also subject to a non-viability contingent capital (NVCC) provision, necessary for the Debentures to qualify as Tier 2 regulatory capital under Basel III. As such, the Debentures are automatically converted into common shares upon the occurrence of a Trigger Event as described in the capital adequacy guidelines. In such an event, the Debentures are convertible into a number of common shares, determined by dividing |
(6) | On June 19, 2024, we redeemed all $ |
(7) | Interest rate is fixed at the indicated rate until the earliest date redeemable at par by CIBC and, thereafter, at a rate of % above the three-month Canadian dollar bankers’ acceptance rate or an appropriate alternative rate. |
(8) | Interest rate is fixed at the indicated rate until the earliest date redeemable at par by CIBC and, thereafter, at a rate of % above the three-month Canadian dollar bankers’ acceptance rate or an appropriate alternative rate. |
(9) | Interest rate is fixed at the indicated rate until the earliest date redeemable at par by CIBC and, thereafter, at Daily Compounded Canadian Overnight Repo Rate Average (CORRA) plus |
(10) | Interest rate is fixed at the indicated rate until the earliest date redeemable at par by CIBC and, thereafter, at Daily Compounded CORRA plus |
(11) | Interest rate is fixed at the indicated rate until the earliest date redeemable at par by CIBC and, thereafter, at Daily Compounded CORRA plus |
(12) | Interest rate is fixed at the indicated rate until the earliest date redeemable at par by CIBC and, thereafter, at Daily Compounded CORRA plus |
(13) | Interest rate is fixed at the indicated rate until the earliest date redeemable at par by CIBC and, thereafter, at Daily Compounded CORRA plus |
(14) | Interest rate is based on the |
(15) | Interest rate is based on the |
CIBC 2024 |
|
159 |
Consolidated financial statements |
Note 15 |
Common and preferred shares and other equity instruments |
$ millions, except number of shares and per share amounts, as at or for the year ended October 31 |
2024 |
2023 |
||||||||||||||||||||||||||||||
Shares outstanding |
Dividends and distributions paid |
Shares outstanding |
Dividends and distributions paid |
|||||||||||||||||||||||||||||
Number of shares |
Amount |
Amount |
$ per share |
Number of shares |
Amount |
Amount |
$ per share |
|||||||||||||||||||||||||
Common shares |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||||||||||
Class A Preferred Shares |
||||||||||||||||||||||||||||||||
Series 39 (1) |
– |
– |
||||||||||||||||||||||||||||||
Series 41 |
||||||||||||||||||||||||||||||||
Series 43 |
||||||||||||||||||||||||||||||||
Series 47 |
||||||||||||||||||||||||||||||||
Series 49 (2) |
– |
– |
||||||||||||||||||||||||||||||
Series 51 (3) |
– |
– |
||||||||||||||||||||||||||||||
Series 56 |
||||||||||||||||||||||||||||||||
Series 57 |
– |
– |
– |
– |
||||||||||||||||||||||||||||
$ |
$ |
$ |
$ |
|||||||||||||||||||||||||||||
Treasury shares – common shares (4) |
$ |
$ |
||||||||||||||||||||||||||||||
Treasury shares – preferred shares (4) |
( |
) |
( |
) |
( |
) |
– |
|||||||||||||||||||||||||
Other Equity Instruments (5) |
||||||||||||||||||||||||||||||||
Limited recourse capital notes Series 1 |
$ |
$ |
$ |
$ |
||||||||||||||||||||||||||||
Limited recourse capital notes Series 2 |
$ |
$ |
$ |
$ |
||||||||||||||||||||||||||||
Limited recourse capital notes Series 3 |
$ |
$ |
$ |
$ |
||||||||||||||||||||||||||||
Limited recourse capital notes Series 4 |
$ |
$ |
– |
$ |
– |
$ |
– |
(1) |
Series 39 preferred shares were redeemed at par value for a total price of $ |
(2) |
Series 49 preferred shares were redeemed at par value for a total price of $ |
(3) |
Series 51 preferred shares were redeemed at par value for a total price of $ |
(4) |
A long position in our own shares is shown as a negative number, which reduces the number of shares outstanding. A short position is shown as a positive number, which adds to the number of shares outstanding. See Note 1 to the consolidated financial statements for the accounting policy on treasury shares. |
(5) |
See the “Limited Recourse Capital Notes (LRCNs)” section below for details. |
$ millions, except number of shares, as at or for the year ended October 31 |
2024 |
2023 |
||||||||||||||
Number of shares |
Amount |
Number of shares |
Amount |
|||||||||||||
Balance at beginning of year |
$ |
|
$ | |
||||||||||||
Issuance pursuant to: |
||||||||||||||||
Equity-settled share-based compensation plans (1) |
||||||||||||||||
Shareholder investment plan (2) |
||||||||||||||||
Employee share purchase plan (3) |
||||||||||||||||
$ |
$ | |||||||||||||||
Purchase of common shares for cancellation |
( |
) |
( |
) |
– | – | ||||||||||
Treasury shares |
( |
) |
– |
( |
) |
( |
) | |||||||||
Balance at end of year |
$ |
$ |
(1) | Includes the settlement of contingent consideration related to prior acquisitions. |
(2) |
Commencing with the dividends paid on July 29, 2024, common shares received by participants were issued from Treasury without a discount. Previously, effective from January 27, 2023, common shares received by participants under the Dividend reinvestment and Stock dividend options within the Shareholder investment plan were issued from Treasury at a |
(3) |
Commencing October 11, 2024, employee contributions to our Canadian ESPP were invested to acquire common shares in the open market. Previously , these shares were issued from Treasury. |
160 |
CIBC 2024 |
Consolidated financial statements |
Outstanding as at October 31, 2024 |
Semi-annually dividends per share (1) |
Quarterly dividends per share (1) |
Earliest specified redemption date |
Cash redemption price per share |
||||||||||||
Series 41 |
$ |
$ |
||||||||||||||
Series 43 |
||||||||||||||||
Series 47 |
||||||||||||||||
Series 56 |
$ |
|||||||||||||||
Series 57 |
(1) |
Dividends may be adjusted depending on the timing of issuance or redemption. |
CIBC 2024 |
|
161 |
Consolidated financial statements |
162 |
CIBC 2024 |
Consolidated financial statements |
CIBC 2024 |
|
163 |
Consolidated financial statements |
$ millions, as at October 31 |
2024 |
2023 |
||||||||
CET1 capital |
$ |
$ |
||||||||
Tier 1 capital |
A |
|||||||||
Total capital |
||||||||||
Total RWA |
B |
|||||||||
CET1 ratio |
% |
% | ||||||||
Tier 1 capital ratio |
% |
% | ||||||||
Total capital ratio |
% |
% | ||||||||
Leverage ratio exposure |
C |
$ |
$ |
|||||||
Leverage ratio |
A/C |
% |
% | |||||||
TLAC available |
D |
$ |
$ |
|||||||
TLAC ratio |
D/B |
% |
% | |||||||
TLAC leverage ratio |
D/C |
% |
% |
164 |
CIBC 2024 |
Consolidated financial statements |
Note 1 6 |
Share-based payments |
CIBC 2024 |
|
165 |
Consolidated financial statements |
As at or for the year ended October 31 |
2024 |
2023 |
||||||||||||||
Number of stock options |
Weighted- average exercise price (1) |
Number of stock options |
Weighted- average exercise price |
|||||||||||||
Outstanding at beginning of year |
$ |
$ | ||||||||||||||
Granted |
||||||||||||||||
Exercised (2) |
( |
) |
( |
) | ||||||||||||
Forfeited/cancelled/expired |
( |
) |
( |
) | ||||||||||||
Outstanding at end of year |
$ |
$ | ||||||||||||||
Exercisable at end of year |
$ |
$ | |
|||||||||||||
Available for grant |
||||||||||||||||
Reserved for future issue |
(1) | For foreign currency-denominated options granted and exercised during the year, the weighted-average exercise prices are converted using exchange rates as at the grant date and settlement date, respectively. The weighted-average exercise price of outstanding balances as at October 31, 2024 reflects the conversion of foreign currency-denominated options at the year-end exchange rate. |
(2) | The weighted-average share price at the date of exercise was $ |
As at October 31, 2024 |
Stock options outstanding |
Stock options vested |
||||||||||||||||||||||
Range of exercise prices |
Number outstanding |
Weighted- average contractual life remaining |
Weighted- average exercise price |
Number outstanding |
Weighted- average exercise price |
|||||||||||||||||||
$1.00 – $40.00 |
$ |
$ |
||||||||||||||||||||||
$40.01 – $50.00 |
||||||||||||||||||||||||
$50.01 – $60.00 |
||||||||||||||||||||||||
$60.01 – $70.00 |
||||||||||||||||||||||||
$70.01 – $80.00 |
– |
|||||||||||||||||||||||
$ |
$ |
For the year ended October 31 |
2024 |
2023 |
||||||
Weighted-average assumptions |
||||||||
Risk-free interest rate |
% |
% | ||||||
Expected dividend yield |
% |
% | ||||||
Expected share price volatility |
% |
% | ||||||
Expected life |
||||||||
Share price/exercise price |
$ |
$ | |
166 |
CIBC 2024 |
Consolidated financial statements |
Note 1 7 |
Post-employment benefits |
CIBC 2024 |
|
167 |
Consolidated financial statements |
Pension plans |
Other post-employment plans |
|||||||||||||||
$ millions, as at or for the year ended October 31 |
2024 |
2023 |
2024 |
2023 |
||||||||||||
Defined benefit obligation |
||||||||||||||||
Balance at beginning of year |
$ |
$ |
$ |
$ |
||||||||||||
Current service cost |
||||||||||||||||
Past service cost |
– |
( |
) |
– |
– |
|||||||||||
Interest cost on defined benefit obligation |
||||||||||||||||
Employee contributions |
– |
– |
||||||||||||||
Benefits paid |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||
Settlement payments |
( |
) |
– |
– |
– |
|||||||||||
Special termination benefits |
– |
– |
– |
|||||||||||||
Foreign exchange rate changes and other |
– |
|||||||||||||||
Net actuarial (gains) losses on defined benefit obligation |
( |
) |
– |
( |
) | |||||||||||
Balance at end of year |
$ |
$ |
$ |
$ |
||||||||||||
Plan assets |
||||||||||||||||
Fair value at beginning of year |
$ |
$ |
$ |
– |
$ |
– |
||||||||||
Interest income on plan assets (1) |
– |
– |
||||||||||||||
Net actuarial gains (losses) on plan assets (1) |
( |
) |
– |
– |
||||||||||||
Employer contributions |
||||||||||||||||
Employee contributions |
– |
– |
||||||||||||||
Benefits paid |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||
Settlement payments |
( |
) |
– |
– |
– |
|||||||||||
Plan administration costs |
( |
) |
( |
) |
– |
– |
||||||||||
Increase (decrease) due to plan settlements |
( |
) |
– |
– |
– |
|||||||||||
Foreign exchange rate changes and other |
– |
– |
||||||||||||||
Fair value at end of year |
$ |
$ |
$ |
– |
$ |
– |
||||||||||
Net defined benefit asset (liability) |
( |
) |
( |
) | ||||||||||||
Valuation allowance (2) |
( |
) |
( |
) |
– |
– |
||||||||||
Net defined benefit asset (liability), net of valuation allowance |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
(1) | The actual return on plan assets for the year was a gain |
(2) | The valuation allowance reflects the effect of asset ceiling on plans with a net defined benefit asset. |
Pension plans |
Other post-employment plans |
|||||||||||||||
$ millions, as at October 31 |
2024 |
2023 |
2024 |
2023 |
||||||||||||
Other assets |
$ |
$ |
$ |
– |
$ |
– |
||||||||||
Other liabilities |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||
$ |
$ |
$ |
( |
) |
$ |
( |
) |
Pension plans |
Other post-employment plans |
|||||||||||||||
$ millions, as at October 31 |
2024 |
2023 |
2024 |
2023 |
||||||||||||
Defined benefit obligation |
||||||||||||||||
Canada |
$ |
$ |
$ |
$ |
||||||||||||
U.S., U.K., and the Caribbean |
||||||||||||||||
Defined benefit obligation at the end of year |
$ |
$ |
$ |
$ |
||||||||||||
Plan assets |
||||||||||||||||
Canada |
$ |
$ |
$ |
– |
$ |
– |
||||||||||
U.S., U.K., and the Caribbean |
– |
– |
||||||||||||||
Plan assets at the end of year |
$ |
$ |
$ |
– |
$ |
– |
168 |
CIBC 2024 |
Consolidated financial statements |
Pension plans |
Other post-employment plans |
|||||||||||||||
$ millions, for the year ended October 31 |
2024 |
2023 |
2024 |
2023 |
||||||||||||
Current service cost (1) |
$ |
$ |
$ |
$ |
||||||||||||
Past service cost |
– |
( |
) |
– |
– |
|||||||||||
Interest cost on defined benefit obligation |
||||||||||||||||
Interest income on plan assets |
( |
) |
( |
) |
– |
– |
||||||||||
Interest expense on effect of asset ceiling |
– |
– |
||||||||||||||
Special termination benefits |
– |
– |
– |
|||||||||||||
Plan administration costs |
– |
– |
||||||||||||||
Net defined benefit plan expense recognized in net income |
$ |
$ |
$ |
$ |
(1) | The 2024 and 2023 current service costs were calculated using separate discount rates of |
Pension plans |
Other post-employment plans |
|||||||||||||||
$ millions, for the year ended October 31 |
2024 (1) |
2023 |
2024 |
2023 |
||||||||||||
Actuarial gains (losses) on defined benefit obligation arising from changes in: |
||||||||||||||||
Demographic assumptions |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
– |
|||||||
Financial assumptions |
( |
) |
( |
) |
||||||||||||
Experience |
( |
) |
||||||||||||||
Net actuarial gains (losses) on plan assets |
( |
) |
– |
– |
||||||||||||
Changes in asset ceiling excluding interest income |
( |
) |
– |
– |
||||||||||||
Net remeasurement gains (losses) recognized in OCI |
$ |
$ |
( |
) |
$ |
– |
$ |
(1) |
Includes the transfer of the accumulated actuarial losses of $ |
Pension plans |
Other post-employment plans |
|||||||||||||||
$ millions, as at October 31 |
2024 |
2023 |
2024 |
2023 |
||||||||||||
Active members |
$ |
$ |
$ |
$ |
||||||||||||
Deferred members |
– |
– |
||||||||||||||
Retired members |
||||||||||||||||
Total |
$ |
$ |
$ |
$ |
Pension plans |
Other post-employment plans |
|||||||||||||||
As at October 31 |
2024 |
2023 |
2024 |
2023 |
||||||||||||
Weighted-average duration, in years |
CIBC 2024 |
|
169 |
Consolidated financial statements |
$ millions, as at October 31 |
2024 |
2023 |
||||||||||||||
Asset category (1) |
||||||||||||||||
Canadian equity securities (2) |
$ |
% |
$ | % | ||||||||||||
Debt securities (3) |
||||||||||||||||
Government bonds |
|
|||||||||||||||
Corporate bonds |
||||||||||||||||
Investment funds (4) |
||||||||||||||||
Canadian equity funds |
– |
– | ||||||||||||||
U.S. equity funds |
||||||||||||||||
International equity funds (5) |
– |
|||||||||||||||
Global equity funds (5) |
||||||||||||||||
Fixed income funds |
||||||||||||||||
Other (2) |
||||||||||||||||
Alternative investments (6) |
||||||||||||||||
Cash and cash equivalents and other |
||||||||||||||||
Obligations related to securities sold under repurchase agreements and securities sold short |
( |
) |
( |
) |
( |
) | ( |
) | ||||||||
$ |
% |
$ | % |
(1) | Asset categories are based upon risk classification including synthetic exposure through derivatives. The fair value of derivatives as at October 31, 2024 was a ne t derivative liability of $ |
(2) | Pension benefit plan assets include CIBC issued securities and deposits of |
(3) | All debt securities held as at October 31, 2024 and 2023 are investment grade, of which $ |
(4) | $ |
(5) | Global equity funds include North American and international investments, whereas International equity funds do not include North American investments. |
(6) | Comprised of private equity, infrastructure, private debt and real estate funds. |
Pension plans |
Other post-employment plans |
|||||||||||||||
As at October 31 |
2024 |
2023 |
2024 |
2023 |
||||||||||||
Discount rate |
% |
% | % |
% | ||||||||||||
Rate of compensation increase (1) |
% |
% | n/a |
n/a |
(1) | Rates of compensation increase for 2024 and 2023 reflect the use of a salary growth rate assumption table that is based on the age and tenure of the employees. The table yields a weighted-average salary growth rate of approximately |
n/a | Not applicable |
As at October 31 |
2024 |
2023 |
||||||
Longevity at age 65 for current retired members |
||||||||
Males |
||||||||
Females |
||||||||
Longevity at age 65 for current members aged 45 |
||||||||
Males |
||||||||
Females |
For the year ended October 31 |
2024 |
2023 |
||||||
Health-care cost trend rates assumed for next year |
% |
% | ||||||
Rate to which the cost trend rate is assumed to decline |
% |
% | ||||||
Year that the rate reaches the ultimate trend rate |
170 |
CIBC 2024 |
Consolidated financial statements |
Estimated increase (decrease) in defined benefit obligation |
Pension plans |
Other post-employment plans |
||||||
$ millions, as at October 31 |
2024 |
2024 |
||||||
Discount rate (100 basis point change) |
||||||||
Decrease in assumption |
$ |
$ |
||||||
Increase in assumption |
( |
) |
( |
) | ||||
Rate of compensation increase (100 basis point change) |
||||||||
Decrease in assumption |
( |
) |
– |
|||||
Increase in assumption |
– |
|||||||
Health-care cost trend rates (100 basis point change) |
||||||||
Decrease in assumption |
n/a |
( |
) | |||||
Increase in assumption |
n/a |
|||||||
Future mortality 1 year shorter life expectancy |
( |
) |
( |
) | ||||
1 year longer life expectancy |
n/a | Not applicable. |
$ millions, for the year ended October 31 |
2025 |
2026 |
2027 |
2028 |
2029 |
2030–2034 |
Total |
|||||||||||||||||||||
Defined benefit pension plans |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
Other post-employment plans |
||||||||||||||||||||||||||||
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | |
$ millions, for the year ended October 31 |
2024 |
2023 |
||||||
Defined contribution pension plans |
$ |
$ | ||||||
Government pension plans (1) |
||||||||
$ |
$ | |
(1) | Includes Canada Pension Plan, Quebec Pension Plan, and U.S. Federal Insurance Contributions Act. |
Note 1 8 |
Income taxes |
$ millions, for the year ended October 31 |
2024 |
2023 (1) |
||||||
Consolidated statement of income |
||||||||
Provision for (reversal of) current income taxes |
||||||||
Adjustments for prior years |
$ |
( |
) |
$ | (2) | |||
Current income tax expense |
||||||||
Provision for (reversal of) deferred income taxes |
||||||||
Adjustments for prior years |
( |
) | ||||||
Effect of changes in tax rates and laws |
( |
) | ||||||
Origination and reversal of temporary differences |
( |
) |
( |
) | ||||
( |
) |
( |
) | |||||
OCI |
( |
) | ||||||
Total comprehensive income |
$ |
$ | |
(1) | Certain prior year information has been restated to reflect the adoption of IFRS 17. See Note 1 to the consolidated financial statements for additional details. |
(2) | The first quarter of 2023 included an income tax charge to recognize the Canada Recovery Dividend (CRD) tax and the retroactive impact of the |
CIBC 2024 |
|
171 |
Consolidated financial statements |
$ millions, for the year ended October 31 |
2024 |
2023 (1) |
||||||
Current income taxes |
||||||||
Federal |
$ |
$ | ||||||
Provincial |
||||||||
Foreign |
||||||||
Deferred income taxes |
||||||||
Federal |
( |
) |
( |
) | ||||
Provincial |
( |
) |
( |
) | ||||
Foreign |
( |
) | ||||||
( |
) |
( |
) | |||||
$ |
$ | |
(1) |
Certain prior year information has been restated to reflect the adoption of IFRS 17. See Note 1 to the consolidated financial statements for additional details. |
$ millions, for the year ended October 31 |
2024 |
2023 (1) |
||||||||||||||
Combined Canadian federal and provincial income tax rate applied to income before income taxes |
$ |
% |
$ | % | ||||||||||||
Income taxes adjusted for the effect of: |
||||||||||||||||
Foreign operations subject to different tax rates |
( |
) |
( |
) |
( |
) | ( |
) | ||||||||
Tax-exempt income |
( |
) |
( |
) |
( |
) | ( |
) | ||||||||
Canada Recovery Dividend (CRD) tax |
– |
– |
||||||||||||||
Other |
( |
) |
( |
) |
( |
) | ( |
) | ||||||||
Income taxes in the consolidated statement of income |
$ |
% |
$ | |
% |
(1) | Certain prior year information has been restated to reflect the adoption of IFRS 17. See Note 1 to the consolidated financial statements for additional details. |
$ millions, for the year ended October 31, 2024 | Net asset Nov. 1, 2023 |
Recognized in net income |
Recognized in OCI |
Other (1) |
Net asset Oct. 31, 2024 |
|||||||||||||||
Allowance for credit losses |
$ |
$ |
$ |
– |
$ |
$ |
||||||||||||||
Deferred compensation |
– |
|||||||||||||||||||
Financial instruments revaluation |
( |
) |
( |
) |
( |
) |
||||||||||||||
Deferred income |
– |
– |
||||||||||||||||||
Other |
||||||||||||||||||||
$ |
$ |
$ |
( |
) |
$ |
$ |
||||||||||||||
Deferred tax liabilities |
||||||||||||||||||||
Intangible assets |
$ |
( |
) |
$ |
( |
) |
$ |
– |
$ |
– |
$ |
( |
) | |||||||
Property and equipment |
( |
) |
( |
) |
– |
( |
) |
( |
) | |||||||||||
Pension and employee benefits |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||
Goodwill |
( |
) |
( |
) |
– |
( |
) |
( |
) | |||||||||||
Financial instruments revaluation |
( |
) |
– |
– |
( |
) | ||||||||||||||
Other |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | ||||||
Total net deferred tax assets |
$ |
$ |
$ |
( |
) |
$ |
$ |
(1) |
Includes foreign currency translation adjustments. |
172 |
CIBC 2024 |
Consolidated financial statements |
$ millions, for the year ended October 31, 2023 |
Net asset Nov. 1, 2022 |
Recognized in net income |
Recognized in OCI |
Other (1) |
Net asset Oct. 31, 2023 (2) |
|||||||||||||||
Allowance for credit losses |
$ |
$ |
$ |
– |
$ |
$ |
||||||||||||||
Deferred compensation |
( |
) |
– |
|||||||||||||||||
Financial instruments revaluation |
( |
) |
( |
) |
– |
|||||||||||||||
Deferred income |
( |
) |
– |
|||||||||||||||||
Other |
– |
– |
( |
) |
||||||||||||||||
$ |
$ |
$ |
( |
) |
$ |
$ |
||||||||||||||
Deferred tax liabilities |
||||||||||||||||||||
Intangible assets |
$ |
( |
) |
$ |
( |
) |
$ |
– |
$ |
( |
) |
$ |
( |
) | ||||||
Property and equipment |
( |
) |
– |
( |
) | |||||||||||||||
Pension and employee benefits |
( |
) |
( |
) | ||||||||||||||||
Goodwill |
( |
) |
( |
) |
– |
– |
( |
) | ||||||||||||
Financial instruments revaluation |
( |
) |
– |
– |
– |
( |
) | |||||||||||||
Other |
( |
) |
( |
) |
( |
) | ||||||||||||||
$ |
( |
) |
$ |
( |
) |
$ |
$ |
$ |
( |
) | ||||||||||
Total net deferred tax assets |
$ |
$ |
$ |
$ |
$ |
(1) |
Includes foreign currency translation adjustments. |
(2) |
Certain prior year information has been restated to reflect the adoption of IFRS 17. See Note 1 to the consolidated financial statements for additional details. |
CIBC 2024 |
|
173 |
Consolidated financial statements |
Note 19 |
Earnings per share |
$ millions, except per share amounts, for the year ended October 31 |
2024 |
2023 (1) |
||||||
Basic EPS |
||||||||
Net income attributable to equity shareholders |
$ |
$ | ||||||
Less: Preferred share dividends and distributions on other equity instruments |
||||||||
Net income attributable to common shareholders |
||||||||
Weighted-average common shares outstanding (thousands) |
||||||||
Basic EPS |
$ |
$ | ||||||
Diluted EPS |
||||||||
Net income attributable to common shareholders |
$ |
$ | ||||||
Weighted-average common shares outstanding (thousands) |
|
|||||||
Add: Stock options potentially exercisable (2) (thousands) |
||||||||
Add: Equity-settled consideration (thousands) |
– |
|||||||
Weighted-average diluted common shares outstanding (thousands) |
||||||||
Diluted EPS |
$ |
$ |
(1) | Certain prior year information has been restated to reflect the adoption of IFRS 17. See Note 1 to the consolidated financial statements for additional details. |
(2) | Excludes average options outstanding of 2024 , as the options’ exercise prices were greater than the average market price of CIBC’s common shares. |
Note 2 0 |
Commitments, guarantees and pledged assets |
$ millions, as at October 31 |
2024 |
2023 (1) |
||||||
Contract amounts |
||||||||
Unutilized credit commitments (2) |
$ |
$ | ||||||
Backstop liquidity facilities |
||||||||
Standby and performance letters of credit |
||||||||
Documentary and commercial letters of credit |
||||||||
Other commitments to extend credit |
||||||||
$ |
$ | |
(1) | Certain information has been revised to conform to the current year presentation. |
(2) | Includes $ |
174 |
CIBC 2024 |
Consolidated financial statements |
$ millions, as at October 31 |
2024 |
2023 |
||||||
Assets pledged in relation to: |
||||||||
Securities lending |
$ |
$ |
||||||
Obligations related to securities sold under repurchase agreements |
||||||||
Obligations related to securities sold short |
||||||||
Securitizations |
||||||||
Covered bonds |
||||||||
Derivatives |
||||||||
Foreign governments and central banks (1) |
||||||||
Clearing systems, payment systems, and depositories (2) |
||||||||
Other |
||||||||
$ |
$ |
(1) | Includes assets pledged to maintain access to central bank facilities in foreign jurisdictions. |
(2) | Includes assets pledged in order to participate in clearing and payment systems and depositories. |
CIBC 2024 |
|
175 |
Consolidated financial statements |
Note 2 1 |
Contingent liabilities and provisions |
176 |
CIBC 2024 |
Consolidated financial statements |
CIBC 2024 |
|
177 |
Consolidated financial statements |
$ millions, for the year ended October 31 |
2024 |
2023 |
||||||
Balance at beginning of year |
$ |
$ |
||||||
Additional new provisions recognized |
||||||||
Less: |
||||||||
Amounts incurred and charged against existing provisions |
( |
) |
( |
) | ||||
Unused amounts reversed and other adjustments (1) |
( |
) |
( |
) | ||||
Balance at end of year |
$ |
$ |
(1) | Includes foreign currency translation adjustments. |
$ millions, for the year ended October 31 |
2024 |
2023 |
||||||
Balance at beginning of year |
$ |
$ |
||||||
Additional new provisions recognized |
||||||||
Less: |
||||||||
Amounts incurred and charged against existing provisions |
( |
) |
( |
) | ||||
Unused amounts reversed |
( |
) |
( |
) | ||||
Balance at end of year |
$ |
$ |
178 |
CIBC 2024 |
Consolidated financial statements |
Note 22 |
Concentration of credit risk |
$ millions, as at October 31 |
2024 |
2023 |
||||||||||||||||||||||||||||||
Canada |
U.S. |
Other countries |
Total |
Canada |
U.S. |
Other countries |
Total |
|||||||||||||||||||||||||
On-balance sheet |
||||||||||||||||||||||||||||||||
Major assets (1)(2)(3) |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||||||||
Off-balance sheet |
||||||||||||||||||||||||||||||||
Credit-related arrangements (4) |
||||||||||||||||||||||||||||||||
Financial institutions |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||||||||
Governments |
||||||||||||||||||||||||||||||||
Retail |
||||||||||||||||||||||||||||||||
Corporate |
||||||||||||||||||||||||||||||||
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
(1) | Major assets consist of cash and deposits with banks, loans and acceptances net of allowance for credit losses, securities, securities borrowed or purchased under resale agreements, and derivative instruments. |
(2) | Includes Canadian currency of $ |
(3) | No industry or foreign jurisdiction accounted for 10% or more of loans and acceptances net of allowance for credit losses, with the exception of the U.S., which accounted for |
(4) |
Certain information has been revised to conform to the current year presentation. |
CIBC 2024 |
|
179 |
Consolidated financial statements |
Note 2 3 |
Related-party transactions |
(1) | Key management personnel are defined as those persons having authority and responsibility for planning, directing and controlling the activities of CIBC directly or indirectly and comprise the members of the Board (referred to as directors), Executive Committee and certain named officers per the Bank Act |
$ millions, for the year ended October 31 |
2024 |
2023 | ||||||||||||||
Directors |
Senior officers |
Directors | Senior officers |
|||||||||||||
Short-term benefits (1) |
$ |
$ |
$ | $ | ||||||||||||
Post-employment benefits |
– |
– | ||||||||||||||
Share-based benefits (2) |
||||||||||||||||
Termination benefits (3) |
– |
– | ||||||||||||||
Total compensation |
$ |
$ |
$ | |
$ | |
(1) | Comprises salaries, statutory and non-statutory benefits related to senior officers and fees related to directors recognized during the year. Also includes annual incentive plan payments related to senior officers on a cash basis. |
(2) | Comprises grant-date fair values of awards granted in the year. |
(3) | Comprises payments made in the period to key management personnel and former key management personnel. |
180 |
CIBC 2024 |
Consolidated financial statements |
Note 2 4 |
Investments in equity-accounted associates and joint ventures |
$ millions, for the year ended October 31 |
2024 |
2023 |
||||||
Net income |
$ |
$ |
||||||
OCI |
||||||||
Total comprehensive income |
$ |
$ |
$ millions, for the year ended October 31 |
2024 |
2023 |
||||||
Net income (loss) |
$ |
$ |
( |
) | ||||
OCI |
– |
|||||||
Total comprehensive income (loss) |
$ |
$ |
( |
) |
CIBC 2024 |
|
181 |
Consolidated financial statements |
Note 2 5 |
Significant subsidiaries |
$ millions, as at October 31, 2024 |
||||||
Subsidiary name (1) |
Address of head or principal office |
Book value of shares owned by CIBC |
(2) | |||
Canada and U.S. |
||||||
$ |
||||||
– |
(3) | |||||
International |
||||||
(4) |
||||||
(1) | Each subsidiary is incorporated or organized under the laws of the state or country in which the principal office is situated, except for Canadian Imperial Holdings Inc., CIBC Inc., CIBC World Markets Corp., CIBC Private Wealth Group, LLC, CIBC Private Wealth Advisors, Inc., and CIBC Bancorp USA Inc., which were incorporated or organized under the laws of the State of Delaware, U.S.; CIBC National Trust Company, which was organized under the laws of the U.S.; and CIBC World Markets (Japan) Inc., which was incorporated in Barbados. |
(2) | The book value of shares of subsidiaries is shown at cost and may include non-voting common and preferred shares. These amounts are eliminated upon consolidation. |
(3) |
The book value of shares owned by CIBC is less than $1 million. |
(4) |
In 2024, FirstCaribbean International Bank Limited and its subsidiaries were rebranded under the CIBC Caribbean name. FirstCaribbean International Bank Limited, FirstCaribbean International Bank and Trust Company (Cayman) Limited, FirstCaribbean International Bank (Bahamas) Limited, FirstCaribbean International Bank (Barbados) Limited, FirstCaribbean International Bank (Cayman) Limited, FirstCaribbean International Bank (Jamaica) Limited, FirstCaribbean International Bank (Trinidad & Tobago) Limited, FirstCaribbean International Trust Company (Bahamas) Limited, and FirstCaribbean International Wealth Management Bank (Barbados) Limited were renamed to CIBC Caribbean Bank Limited, CIBC Caribbean Bank and Trust Company (Cayman) Limited, CIBC Caribbean Bank (Bahamas) Limited, CIBC Caribbean Bank (Barbados) Limited, CIBC Caribbean Bank (Cayman) Limited, CIBC Caribbean Bank (Jamaica) Limited, CIBC Caribbean Bank (Trinidad and Tobago) Limited, CIBC Caribbean Trust Company (Bahamas) Limited, and CIBC Caribbean Wealth Management Bank (Barbados) Limited, respectively. |
182 |
CIBC 2024 |
Consolidated financial statements |
Note 2 6 |
Financial instruments – disclosures |
Description |
Section |
|||
For each type of risk arising from financial instruments, an entity shall disclose: the exposure to risks and how they arise; objectives, policies and processes used for managing the risks; methods used to measure the risk; and description of collateral. | Risk overview |
|||
Credit risk |
||||
Market risk |
||||
Liquidity risk |
||||
Operational risk |
||||
Reputation and legal risks |
||||
Conduct risk |
||||
Regulatory compliance risk |
||||
Credit risk: gross exposure to credit risk, credit quality and concentration of exposures. |
Credit risk |
|||
Market risk: trading portfolios – Value-at-Risk; non-trading portfolios – interest rate risk, foreign exchange risk and equity risk. |
Market risk |
|||
Liquidity risk: liquid assets, maturity of financial assets and liabilities, and credit commitments. |
Liquidity risk |
$ millions, as at October 31 |
IRB approach |
Standardized approach |
Other credit risk (1) |
Securitization approach |
Total subject to credit risk |
Not subject to credit risk |
Total consolidated balance sheet |
|||||||||||||||||||||||
2024 |
Cash and deposits with banks |
$ |
$ |
$ |
$ |
– |
$ |
$ |
– |
$ |
||||||||||||||||||||
Securities |
– |
|||||||||||||||||||||||||||||
Cash collateral on securities borrowed |
– |
– |
– |
|||||||||||||||||||||||||||
Securities purchased under resale agreements |
– |
– |
||||||||||||||||||||||||||||
Loans |
||||||||||||||||||||||||||||||
Allowance for credit losses |
( |
) |
( |
) |
– |
– |
( |
) |
– |
( |
) | |||||||||||||||||||
Derivative instruments |
– |
– |
– |
– |
||||||||||||||||||||||||||
Customers’ liability under acceptances |
– |
– |
– |
– |
||||||||||||||||||||||||||
Other assets |
||||||||||||||||||||||||||||||
Total credit exposures |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||||
2023 (2) (3) |
Total credit exposures |
$ | |
$ | |
$ | |
$ | |
$ | |
$ | $ |
(1) |
Includes credit risk exposures arising from other assets that are subject to the credit risk framework but are not included in the standardized or IRB frameworks, including other balance sheet assets which are risk-weighted at 100%, significant investments in the capital of non-financial institutions, and amounts below the thresholds for capital deduction that are risk-weighted at 250%. |
(2) |
Certain prior year information has been restated to conform to the current year presentation. |
(3) |
Certain prior year information has been restated to reflect the adoption of IFRS 17. See Note 1 to the consolidated financial statements for additional details. |
CIBC 2024 |
|
183 |
Consolidated financial statements |
Note 2 7 |
Offsetting financial assets and liabilities |
Amounts subject to enforceable netting agreements |
||||||||||||||||||||||||||||||||||
Gross amounts of recognized financial instruments |
Gross amounts offset on the consolidated balance sheet |
(1) |
Related amounts not set-off onthe consolidated balance sheet |
Amounts not subject to enforceable netting agreements |
(4) |
Net amounts presented on the consolidated balance sheet |
||||||||||||||||||||||||||||
$ millions, as at October 31 |
Net amounts |
Financial instruments |
(2) |
Collateral received |
(3) |
Net amounts |
||||||||||||||||||||||||||||
2024 |
Financial assets |
|||||||||||||||||||||||||||||||||
Derivatives |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
$ |
||||||||||||||||||||
Cash collateral on securities borrowed |
– |
– |
( |
) |
– |
|||||||||||||||||||||||||||||
Securities purchased under resale agreements |
( |
) |
– |
( |
) |
– |
||||||||||||||||||||||||||||
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
$ |
|||||||||||||||||||||
Financial liabilities |
||||||||||||||||||||||||||||||||||
Derivatives |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
$ |
||||||||||||||||||||
Cash collateral on securities lent |
– |
– |
( |
) |
– |
|||||||||||||||||||||||||||||
Obligations related to securities sold under repurchase agreements |
( |
) |
– |
( |
) |
– |
||||||||||||||||||||||||||||
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
$ |
|||||||||||||||||||||
2023 |
Financial assets |
|||||||||||||||||||||||||||||||||
Derivatives |
$ | $ | ( |
) | $ | $ | ( |
) | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||
Cash collateral on securities borrowed |
– | – | ( |
) | – | |||||||||||||||||||||||||||||
Securities purchased under resale agreements |
( |
) | – | ( |
) | – | ||||||||||||||||||||||||||||
$ | $ | ( |
) | $ | $ | ( |
) | $ | ( |
) | $ | $ | $ | |||||||||||||||||||||
Financial liabilities |
||||||||||||||||||||||||||||||||||
Derivatives |
$ | $ | ( |
) | $ | $ | ( |
) | $ | ( |
) | $ | $ | $ | ||||||||||||||||||||
Cash collateral on securities lent |
– | – | ( |
) | – | |||||||||||||||||||||||||||||
Obligations related to securities sold under repurchase agreements |
( |
) | – | ( |
) | – | ||||||||||||||||||||||||||||
$ | |
$ | ( |
) | $ | |
$ | ( |
) | $ | ( |
) | $ | |
$ | |
$ | |
(1) | Comprises amounts related to financial instruments which qualify for offsetting. This amount excludes derivatives which are settled-to-market |
(2) | Comprises amounts subject to set-off under enforceable netting agreements, such as ISDA agreements, derivative exchange or clearing counterparty agreements, global master repurchase agreements, and global master securities lending agreements. Under such arrangements, all outstanding transactions governed by the relevant agreement can be offset if an event of default or other predetermined event occurs. |
(3) | Collateral received and pledged amounts are reflected at fair value, but have been limited to the net balance sheet exposure so as not to include any over-collateralization. |
(4) | Includes exchange-traded derivatives and derivatives which are STM. |
Note 2 8 |
Interest income and expense |
$ millions, for the year ended October 31 |
Interest income |
Interest expense |
||||||||
2024 |
Measured at amortized cost (1)(2) |
$ |
$ |
|||||||
Debt securities measured at FVOCI (1) |
n/a |
|||||||||
Other (3) |
||||||||||
Total |
$ |
$ |
||||||||
2023 | Measured at amortized cost (1)(2) |
$ | $ | |||||||
Debt securities measured at FVOCI (1) |
n/a | |||||||||
Other (3) |
||||||||||
Total |
$ | $ |
(1) | Interest income for financial instruments that are measured at amortized cost and debt securities that are measured at FVOCI is calculated using the effective interest rate method. |
(2) | Includes interest income on sublease-related assets and interest expense on lease liabilities under IFRS 16. |
(3) | Includes interest income and expense and dividend income for financial instruments that are mandatorily measured and designated at FVTPL and equity securities designated at FVOCI. |
n/a | Not applicable. |
184 |
CIBC 2024 |
Consolidated financial statements |
Note 29 |
Segmented and geographic information |
CIBC 2024 |
|
185 |
Consolidated financial statements |
$ millions, for the year ended October 31 |
Canadian Personal and Business Banking (1) |
Canadian Commercial Banking and Wealth Management |
U.S. Commercial Banking and Wealth Management |
Capital Markets and Direct Financial Services |
Corporate and Other |
CIBC Total |
Canada (1)(2) |
U.S. (2) |
Caribbean (2) |
Other countries (2) |
||||||||||||||||||||||||||||||||
2024 |
Net interest income (3) |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||||||||||||
Non-interest income (4)(5) |
||||||||||||||||||||||||||||||||||||||||||
Total revenue |
||||||||||||||||||||||||||||||||||||||||||
Provision for credit losses |
||||||||||||||||||||||||||||||||||||||||||
Amortization and impairment (6) |
||||||||||||||||||||||||||||||||||||||||||
Other non-interest expenses |
||||||||||||||||||||||||||||||||||||||||||
Income (loss) before income taxes |
( |
) |
||||||||||||||||||||||||||||||||||||||||
Income taxes (3) |
( |
) |
||||||||||||||||||||||||||||||||||||||||
Net income |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||||||||||||||||
Net income attributable to: |
||||||||||||||||||||||||||||||||||||||||||
Non-controlling interests |
$ |
– |
$ |
– |
$ |
– |
$ |
– |
$ |
$ |
$ |
– |
$ |
– |
$ |
$ |
– |
|||||||||||||||||||||||||
Equity shareholders |
||||||||||||||||||||||||||||||||||||||||||
Average assets (7)(8) |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||||||||||||||||
2023 |
Net interest income (3) |
$ |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||||||||||
Non-interest income (4)(5) |
||||||||||||||||||||||||||||||||||||||||||
Total revenue |
||||||||||||||||||||||||||||||||||||||||||
Provision for (reversal of) credit losses |
( |
) | ||||||||||||||||||||||||||||||||||||||||
Amortization and impairment (6) |
||||||||||||||||||||||||||||||||||||||||||
Other non-interest expenses |
||||||||||||||||||||||||||||||||||||||||||
Income (loss) before income taxes |
( |
) |
||||||||||||||||||||||||||||||||||||||||
Income taxes (3) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||||||||||
Net income (loss) |
$ |
$ |
$ |
$ |
$ |
( |
) |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||||||||||||||
Net income (loss) attributable to: |
||||||||||||||||||||||||||||||||||||||||||
Non-controlling interests |
$ |
– |
$ |
– |
$ |
– |
$ |
– |
$ |
$ |
$ |
– |
$ |
– |
$ |
$ |
– |
|||||||||||||||||||||||||
Equity shareholders |
( |
) |
||||||||||||||||||||||||||||||||||||||||
Average assets (7)(8) |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
(1) | Certain prior year information has been restated to reflect the adoption of IFRS 17. See Note 1 to the consolidated financial statements for additional details. |
(2) | Net income and average assets are allocated based on the geographic location where they are recorded. |
(3) | Capital Markets and Direct Financial Services net interest income and income taxes include taxable equivalent basis (TEB) adjustments of $ |
(4) | The fee and commission income within non-interest income consists primarily of underwriting and advisory fees, deposit and payment fees, credit fees, card fees, investment management and custodial fees, mutual fund fees and commissions on securities transactions. Underwriting and advisory fees are earned primarily in Capital Markets and Direct Financial Services with the remainder earned in Canadian Commercial Banking and Wealth Management. Deposit and payment fees are earned primarily in Canadian Personal and Business Banking, with the remainder earned mainly in Canadian Commercial Banking and Wealth Management, Capital Markets and Direct Financial Services, and Corporate and Other. Credit fees are earned primarily in Canadian Commercial Banking and Wealth Management, Capital Markets and Direct Financial Services, and U.S. Commercial Banking and Wealth Management. Card fees are earned primarily in Canadian Personal and Business Banking, with the remainder earned mainly in Corporate and Other. Investment management and custodial fees are earned primarily in Canadian Commercial Banking and Wealth Management and U.S. Commercial Banking and Wealth Management, with the remainder earned mainly in Corporate and Other. Mutual fund fees are earned primarily in Canadian Commercial Banking and Wealth Management and U.S. Commercial Banking and Wealth Management. Commissions on securities transactions are earned primarily in Capital Markets and Direct Financial Services, and Canadian Commercial Banking and Wealth Management. |
(5) | Includes intersegment revenue, which represents internal sales commissions and revenue allocations under the Product Owner/Customer Segment/Distributor Channel allocation management model. |
(6) | Comprises amortization and impairment of buildings, right-of-use |
(7) | Assets are disclosed on an average basis as this measure is most relevant to a financial institution and is the measure reviewed by management. |
(8) | Average balances are calculated as a weighted average of daily closing balances. |
$ millions, for the year ended October 31 |
2024 |
2023 | ||||||
Canadian Personal and Business Banking |
$ |
$ | |
(1) | ||||
Canadian Commercial Banking and Wealth Management |
||||||||
Commercial banking |
$ |
$ | ||||||
Wealth management |
||||||||
$ |
$ | |||||||
U.S. Commercial Banking and Wealth Management |
||||||||
Commercial banking |
$ |
$ | ||||||
Wealth management |
||||||||
$ |
$ | |||||||
Capital Markets and Direct Financial Services (2) |
||||||||
Global markets |
$ |
$ | ||||||
Corporate and investment banking |
||||||||
Direct financial services |
||||||||
$ |
$ | |||||||
Corporate and Other (2) |
||||||||
International banking |
$ |
$ | ||||||
Other |
( |
) | ||||||
$ |
$ |
(1) | Certain prior year information has been restated to reflect the adoption of IFRS 17. See Note 1 to the consolidated financial statements for additional details. |
(2) | Capital Markets and Direct Financial Services revenue includes a TEB adjustment of $ |
186 |
CIBC 2024 |
Consolidated financial statements |
Note 3 0 |
Future accounting policy changes |
CIBC 2024 |
|
187 |